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Abstract 
 
Household studies, sometimes referred to as community or family studies, have 
contributed immensely to our understanding of acute respiratory illnesses (ARI) from identifying 
causal agents to estimating vaccine effectiveness. The Household Influenza Vaccine 
Effectiveness (HIVE) study is an ongoing, prospective cohort study of ARI in households with 
children in the Ann Arbor, Michigan area. This dissertation uses data from years one (2010-
2011) through four (2012-2013) of the HIVE Study to address two topics related to the 
prevention and spread of respiratory viruses in the household setting.  
First, there has been substantial research on determinants of influenza vaccine receipt in 
health care workers and pregnant women, but much less in community dwelling adults and 
children. We used a theoretical framework based on the Health Belief Model to examine the 
factors associated with influenza vaccine receipt in adults and their children. We found that not 
only are factors such as perceived benefits and barriers associated with vaccine uptake, but that 
many of these factors are modified by external motivators, such as doctor recommendation. 
Second, a phenomenon that has been termed viral interference has been proposed to explain 
ecologic trends in viral incidence, particularly with respect to influenza and respiratory syncytial 
virus (RSV). We used two distinct approaches to determine if there was evidence of viral 
interference across multiple years of HIVE Study surveillance. The first used an ecologic 
analysis common in the field of economics to examine trends in viral incidences. In addition, we 
used an individual based approach to examine the risk of influenza after previous ARI.  While 
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trends in viral incidences are correlated, we found little consistent evidence for viral interference, 
though further work is needed.  
Collectively, this dissertation highlights the value of a prospective cohort study of ARI in 
the household setting by illustrating the breadth of topics that can be investigated.
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Chapter 1. Background and Significance 
 
Introduction 
Households are widely regarded as an important contributor to the spread of infectious 
diseases, including respiratory viruses such as influenza. The history of studying acute 
respiratory illnesses (ARI) in this setting dates back to the beginning of the 20th century [1] and 
continued through the early 1980’s [2]. Many of these early studies produced a wealth of 
information, specifically with regards to the basic epidemiologic understanding of these 
illnesses. Advances in laboratory techniques have improved our ability to detect etiologic agents 
associated with respiratory illnesses, and, therefore an update of these previous studies is 
necessary.  
The Household Influenza Vaccine Effectiveness (HIVE) study is an ongoing, prospective 
cohort study. It was originally envisioned as a companion study to a test-negative design, multi-
center study of influenza vaccine effectiveness in order to evaluate the validity of this relatively 
new approach. A prospective cohort is a unique setting to study influenza that can suffer from 
limited power to detect an effect in years with low risk of infection. However, it is also a 
convenient study design when it comes to addressing novel questions and developing and testing 
multiple hypotheses and evaluating multiple outcomes. 
There are several gaps in the understanding of factors that influence the prevention and 
spread of influenza in households. While far from an exhaustive list we have focused on two 
topics that are illustrative of areas where our understanding of this disease can be advanced. 
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First, determinants of vaccine uptake have been described in health care workers, pregnant 
women, and children with high-risk conditions (e.g. asthma) [3-10]. However, no studies have 
looked at factors that influence vaccine uptake for adults in comparison to those for the children 
in their household. Additionally, hypothesis-generating studies have described trends in 
seasonality of Respiratory Syncytial Virus (RSV) and influenza and the fact that these viruses 
both circulate in the winter months [2, 11]. However these studies rely on ecologic observations 
without statistical evaluation. Very few studies have attempted to investigate this phenomenon at 
the individual level, and results are inconclusive [12, 13]. 
Specific Aims and Hypotheses 
The specific aims and hypotheses addressed by this dissertation are, therefore, as follows: 
Aim 1: To describe and compare the factors that affect the decisions to get one’s self and 
children in one’s household vaccinated against influenza. 
Hypothesis: Using a health belief framework to measure knowledge, attitudes and 
practices, we hypothesize that adults who report higher levels of perceived benefits, and lower 
levels of perceived barriers regarding influenza vaccination are more likely to get themselves and 
the children in their household vaccinated. 
 
Aim 2: To examine potential virus interference by describing trends in influenza and 
other respiratory virus circulation and statistically evaluating if incidence of one virus is 
correlated with and/or predictive of incidence of another virus.  
Hypothesis: Viral incidence is correlated and the incidence of respiratory viruses that 
circulate in the fall or early winter (specifically rhinovirus and coronaviruses) can predict the 
circulation of those that occur later in the winter (specifically influenza at RSV). 
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Aim 3: To examine virus interference at the individual level by estimating the relative 
risk of influenza infection among those with a previous ARI (used as a proxy for previous viral 
infection) compared to those with no previous ARI.  
Hypothesis: The risk of influenza will be lower for those who experienced a previous 
ARI, and the risk of influenza will increase as length of time since the previous illness increases.  
 
Background and significance 
Seasonal influenza causes approximately 150,000 hospitalizations and 30,000 – 40,000 
deaths annually in the United States alone and the annual economic burden of influenza, 
accounting for premature death, lost wages, and direct health care costs, is estimated to be $87 
billion [14-16]. Household transmission is thought to be a major driver of seasonal influenza 
epidemics and pandemics as well as epidemics of non-influenza respiratory viruses [17]. Further, 
decisions about various prevention strategies such as vaccination and hand hygiene may be made 
at the household level, particularly in households with young children. Indeed, recent findings 
indicate that, even among adolescents and teenagers, children are influenced by their parent’s 
attitudes and behaviors about vaccination [14, 18]. Isolation of ill individuals in the home is also 
recommended as a non-pharmaceutical intervention (NPI) for limiting the spread of both 
seasonal and pandemic influenza [19]. Given the importance of the households for prevention 
and transmission of influenza, studies in this environment are extremely valuable. Prospective 
cohort studies are an incredibly useful way to evaluate many of the uncertainties that remain 
surrounding the transmission, pathogenesis, and prevention of influenza and other respiratory 
viruses [20]. 
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Household Studies of Respiratory Illness  
Household cohort studies, or family studies, have been used to study respiratory illnesses 
since the early parts of the 20th century. The design was first used by Edgar Sydenstricker in 
1921 in Hagerstown, MD and was closely replicated by Wade Hampton Frost seven years later 
in Baltimore [1, 21]. These studies were conducted prior to the identification of influenza as a 
causative agent of respiratory illness but nonetheless contributed to our current understanding of 
disease. Sydenstricker, for example, showed that “colds and bronchitis” and “influenza and 
grippe” were the two most commonly reported acute illnesses [1]. Frost used illness diaries and 
demonstrated seasonal patterns of illness and found that incidence decreased with age with the 
exception of adults in the 20-39 year old age group [21, 22]. A brief history of household or 
family studies has been adapted from a review by Monto and is presented in table 1-1 [23]. 
The three seminal studies using this design began with the Cleveland Family Study, 
which ran from 1948-1957 and was followed by the Virus Watch studies of New York (1961-
1965) and Seattle (1965-1969) and the Tecumseh Study of Respiratory Illness (1965-1971 and 
1976-1981). These studies provided invaluable information about influenza and other respiratory 
infections. In Cleveland they showed that school children have the highest incidence of 
respiratory disease, followed by mothers and pre-school children [24]. Meanwhile, the Virus 
Watch studies described sub-clinical infection of rhinovirus, adenovirus, and RSV using 
serologic evidence of infection that was not linked to a reported illness [25, 26]. Examples of 
major findings from Tecumseh include identifying phenomena such as the role vaccinating 
children can have to limit community wide spread of influenza [27], describing basic 
epidemiology [25, 26, 28, 29], and explaining environmental factors that influence the spread of 
respiratory disease [30]. The Houston Family Study of respiratory illness, which began in 1976, 
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took a slightly different approach, enrolling low income households that had sought obstetric 
care and given birth to an infant at the public hospital [31].  Findings of note from this study 
include the fact that individuals living in households with school aged children were at higher 
risk of infection and that the risk primary infection with RSV is highest in the first and second 
years of life [2, 32, 33]. In addition to these empirical findings, data from many these studies 
have informed the parameters included in dynamic transmission models that have, in turn, been 
used to make policy decisions to limit the spread of pandemics [17, 19, 34].  
These examples, like all epidemiologic studies, have limitations. Some, for example, had 
small sample sizes. Some made inferences based on serologic evidence of infection, rather than 
identification of a causative virus [35]. Advances in molecular methods for virus identification, 
specifically those based on the polymerase chain reaction (PCR), make updating the results of 
these previous analyses important and cost effective. Moreover, important parameters for 
transmission such as contact patterns of household members (e.g. children in daycare) and 
household size have most likely changed over the past 4 decades.  
An update of the household cohort study may also be of value in that currently many of 
the most influential studies for influenza vaccine effectiveness (VE) estimates are designed 
around medically attended illnesses using a test-negative control design. The effects of 
information bias related to this study design have been described in simulation studies, and 
appear to result in an underestimate of VE [36]. Importantly, other sources of bias (e.g. selection) 
that may have a greater impact on the estimates have not been evaluated thoroughly. The 
Household Influenza Vaccine Effectiveness (HIVE) study was designed and is currently being 
conducted with the expressed purpose of addressing these previous limitations. The prospective 
cohort design and recent technological advances (e.g. online survey distribution software) allow 
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us to evaluate many additional research questions outside the primary objective without a major 
increase in funding or resources. Of the endless possibilities, we have identified the two specific 
topics described above that warrant further research and that will be addressed in this 
dissertation. 
Household Influenza Vaccine Effectiveness (HIVE) study 
 This dissertation makes use of data from the first four years of the HIVE Study. 
Beginning in the 2010-2011 season, we recruited a cohort of households with children, in the 
Ann Arbor area, for a longitudinal study of influenza and influenza vaccine effectiveness.  The 
building block of this study is the Tecumseh Study of Respiratory Illnesses, with some updated 
methods to adapt to changes in family dynamics, societal norms, and community settings.  As the 
name suggests the HIVE Study was designed to estimate influenza vaccine effectiveness, 
specifically in preventing influenza illnesses of any severity. Vaccine effectiveness estimates 
were initially intended to complement and evaluate the potential for bias from contemporaneous 
studies of influenza vaccine effectiveness in the ambulatory care setting that use a test-negative 
design. Influenza vaccination status is determined by examining documented evidence of receipt 
in the medical record or state registry documented, and considered with PCR-confirmed 
influenza outcomes to estimate influenza vaccine effectiveness. We further process all 
respiratory specimens by real-time, reverse transcriptase polymerase chain reaction (RT-PCR), 
using primers/probes and protocols developed by Dr. Dean Erdman at the CDC, to identify 11 
additional non-influenza viruses: Human Metapneumovirus (HMPV), Respiratory Syncytial 
Virus (RSV), rhinovirus, parainfluenza (types 1-3), coronavirus (types HKU1, OC43, NL63, and 
229E), and adenovirus. Respiratory specimens were collected from symptomatic household 
members at study illness visits and illnesses were followed for collection of data on duration, 
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seeking medically attention, plus estimates of illness burden (work/school days lost). Blood 
specimens were collected to examine susceptibility and immune response to influenza infection 
and to vaccination at up to three time points annually beginning in the second year of the study 
(2011-2012).  Serologic studies may also allow some estimation of asymptomatic infection; for 
influenza, the role of asymptomatic infection in transmission remains an unanswered question. 
Additional data are collected via survey and factors predicting influenza vaccination, medical 
care- seeking behavior and household contact patterns examined.   
Year one (2010-2011) 
In the summer of 2010 we identified the cohort of potentially eligible households with 
help from the Clinical Data Repository (CDR) at the University of Michigan Health System 
(UMHS). This list of households was drawn from individuals with a primary health care provider 
identified within UMHS based in Ann Arbor.  Eligible households had at least four members, at 
least two of whom were children less than 18 years old.  CDR identified approximately 6500 
households, and we excluded approximately 2000 households because their residence was 
located outside the local study area or because no individual had a recent contact (within one 
year) with a UMHS provider.  4,511 households were subsequently targeted for recruitment and 
mailed and invitation to participate in the study.  Targeted households were given the 
opportunity to opt in or out of further contact from study staff by completing and returning a 
postcard.  In October 2010, at the end of the enrollment period, 328 households were enrolled.  
The mean size of the 328 enrolled households at enrollment was 4.4 members with a range of 4 
to 9 members (Table 1-2).  1,441 individuals enrolled; 51% of subjects were female (n=728), 
58% (n=840) were children less than 18 years old, and most (99%) reported having health 
insurance. 125 (9%) participants had an ARI associated with laboratory-confirmed influenza and 
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influenza was introduced to 78 (24%) households [37]. We observed transmission to exposed 
household members in 23 households.  Households with a lower mean age and those that did not 
report home humidification were more likely to have influenza transmitted to household 
members exposed to an index case. However, we did not detect any association with the 
proportion of individuals vaccinated in the household.  The overall secondary infection risk was 
10% and young children (less than nine years old) were those at highest risk. Secondary infection 
risk and the serial interval also varied substantially by influenza type/subtype with the highest 
risk for influenza A (H3N2) [49].     
Year two (2011-2012) 
Recruitment for the 2011-12 study year did not start until early October 2011 and we 
only targeted 303 households, 92% of those who had actively participated during the previous 
season. Active participation was defined as those households that had completed any of the 
following criteria: reported at least one ARI, completed at least one survey, and/or submitted a 
vaccination report card. We further targeted households that had expressed interest in 
participating the previous season, but who had not had the opportunity to enroll after sample size 
goals were met.  Recruitment challenges resulted in only 213 households enrolled for the 2011-
12 season, 65% of the total from the previous year; 197 (92%) enrolled households had 
participated the previous year.  Household characteristics were similar to the previous cohort: 
mean household size was 4.4 members with a range of 4-9 members and mean age of 23 years.  
A total of 943 individuals were enrolled, 463 (49%) were female and 551 (58%) were children 
<18 years (Table 1-2).  Low influenza attack rates in the relatively mild 2011-2012 season made 
evaluation of vaccine effectiveness difficult.  .   
 Year three (2012-2013) 
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For the 2012-2013 study year, the cohort of eligible households was updated using the 
strategy described for year one (2010-2011) and recruitment was again carried out during the 
summer months. To maximize returns and allow for longitudinal assessments across study years, 
we initially targeted households that participated in 2011-2012 and remained eligible. Enrollment 
numbers were supplemented by recruiting study eligible households from the targeted cohort, as 
defined above for study year 2010-2011. 150 (83%) of the 181 previously participating 
households reported interest in continuing to participate and 147 were enrolled. 222 additional 
households that received direct mail invitation to participate reported interest and 164 (74%) 
were enrolled. The local 2012-2013 influenza season began earlier than previous seasons with 
circulation of influenza A/H3, B/Yamagata and B/Victoria viruses, and occasional cases of 
influenza A/H1. Surveillance activities ended in April 2013.  
During the 2012-2013 season, influenza was identified in 76 (24%) households and 111 
(8%) individuals; the infection risk was 6.6% in the vaccinated and 9.5% in the unvaccinated (P 
<.05) [38]. We used data from the first three surveillance seasons (2010-2011, 2011-2012 and 
2012-2013) to examine frequency of ARI and circulation of influenza and non-influenza 
respiratory viruses. Individuals living in larger households (>4 members) and those living in 
households with children age less than five years old had significantly higher frequency of ARI 
[39]. At the individual level, ARI frequency generally declined with increasing age.  A virus was 
most likely to be detected in respiratory specimens from young children, who were also most 
likely to have virus co-infection.  Overall, 16% of ARIs with one virus identified had one or 
more co-infecting viruses [39].   
Year four (2013-2014) 
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In the interest of assembling a cohort that was more representative of southeast Michigan, 
and more easily generalized to external populations, we updated our recruitment strategy in year 
four. Specifically, we identified potentially eligible households by including those who received 
care at either the UMHS or the Henry Ford (HF) health system in Detroit. The strategy for 
selecting the study population was planned to be identical at both health systems, and utilize the 
same strategy described above for the 2010-2011 and 2012-2013 study years.  Unfortunately, the 
pool of potentially eligible households at HF was smaller than anticipated (~N=1,700) and 
sample size goals were not met at that site.  Further, questions arose about low participation in 
study activities, specifically reporting ARI and attending illness visits at the HF site. Therefore, 
the 2013-2014 study data in this dissertation is limited to those households that enrolled at the 
UM study site. A total of 290 households with 1297 subjects were recruited for the 2013-2014 
study year; 232 households and 1049 subjects from the UM site; 58% of enrolled subjects were 
children <18 years (Table 1-2). Surveillance activities began October 1, 2013 and ended April 
11, 2014. Influenza was identified in 55 (7%) specimens. The local 2013-2014 influenza season 
began earlier than previous seasons and primarily consisted of circulation of pandemic influenza 
A (H1N1) [39].  
Determinants of influenza vaccine receipt  
Influenza vaccine is widely recognized as the first line of defense against influenza 
infection. Beginning in 2010 the Advisory Committee for Immunization Practices (ACIP) issued 
a recommendation that all persons over 6 months of age in the United States receive an annual 
influenza vaccine [40]. Despite this “universal” recommendation from public health authorities, 
vaccination rates remain well below optimal levels. In 2009-2010, during the pandemic, 
nationwide coverage estimates indicate that vaccination was on the rise for children and 
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remained stable for adults. Overall, however, only 41% of people received the 2009-2010 
seasonal influenza vaccine [41]. Research on determinants of vaccination has primarily focused 
on health care workers, pregnant women, or the elderly [10, 42-44]. Recently, studies have 
begun to examine vaccine uptake in specific populations of children (e.g. those with asthma, < 5 
years old) [4, 7, 45]. There has been substantially less research on the determinants in 
community dwelling adults and children of all ages, and no research on factors that predict 
receipt of vaccine for adults and children in the same household. 
Predictors of influenza vaccine have been studied extensively in health care workers [5, 
6, 10, 43, 46, 47]. These studies often find that previous vaccine receipt, perceived effectiveness, 
and convenience are significant predictors of uptake of influenza vaccine. The authors of a recent 
review conclude that the primary motivation for health care workers that receive the vaccine is 
self-protection [43]. Health care workers are, in important ways, different than the general 
public. First and foremost they are, by definition, employed, which means they are more likely to 
be insured and have better access to care. Moreover, many employers are now compelling health 
care workers to get vaccinated by instituting mandatory vaccination policies. As a result vaccine 
coverage has been recently observed to be much higher in health care workers than in the general 
public [46]. While the health care industry is growing bigger every year, it is still a relatively 
small slice of the population. In order to achieve optimal levels of vaccine coverage (i.e. 
establish herd immunity) we will need to focus on the general population [48].  
With that in mind, a current trend in vaccine determinants research is examining parental 
attitudes toward influenza vaccination [3, 7-9, 14, 18, 43, 45, 47, 49]. Many of these analyses 
have only examined a) young children [8, 49] b) attitudes related to the pandemic H1N1 vaccine 
[14, 18, 50] and c) children with high-risk conditions. [4, 9, 45]  ACIP recommendations have 
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often dictated the age group under study. For example, during the 2003-2004 influenza season 
researchers found that a doctor recommendation was strongly associated with vaccine receipt but 
only surveyed parents of children 6 – 21 months old.[49] Similarly, Soyer et al. and Lin et al. 
separately found that doctor recommendation was a significant predictor of vaccination for 
children with high-risk conditions.[4, 9] Flood et al. (2010) conducted an online survey to gauge 
parental attitudes toward vaccinating their children. They found that perceived risk of influenza 
and perceived safety and effectiveness of the vaccine were associated with an increased intention 
to get children vaccinated [3]. The authors also identified the Health Belief Model (HBM) as the 
appropriate theoretical framework for examining parental attitudes.  However, this study was 
limited to younger children (i.e. those 2-12 years of age) and did not attempt to evaluate either 
actual vaccine receipt or parental attitudes about receiving the vaccine for themselves.  
The importance of understanding vaccine predictors in community-dwelling adults has 
also begun to be recognized. This research has focused, principally, on the factors that determine 
receipt of pandemic vaccine [51-53]. Liao et al (2011), for example, described predictors of 
vaccination in community-dwelling adults in Singapore during the 2009 pandemic, but did not 
assess factors associated with vaccine uptake among their children [51]. Yi and colleagues also 
found that vaccinated adults (based on self-report) were more likely to have higher perceived 
risk, an underlying high-risk condition, and to have received an influenza vaccine the previous 
year [52]. No studies, however, have compared the factors associated with documented receipt of 
seasonal influenza vaccine for parents who make a vaccine decision for themselves and for the 
children in their household.  
Nearly all of these studies rely on self-report or behavioral intention to determine 
vaccination status. Clearly both of these outcomes are susceptible to misclassification of “true” 
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receipt of vaccine. For example, intention has been strongly associated with actual receipt of 
vaccine, but actual receipt is often lower [10, 54]. Additionally, parental report of childhood 
vaccination has shown to be relatively accurate (though less so than medical record 
confirmation) in children seeking medical care for acute febrile illness during the pandemic [55]. 
In contrast it was found not to be very accurate for parents of children with high-risk conditions 
during a non-pandemic year [4, 8]. It is plausible, that given the extensive media attention 
surrounding the pandemic, and the fact that the children were experiencing symptoms of an 
influenza-like illness the recall in the first study was better than can be expected from the general 
population.  
Our analysis will advance the understanding of factors associated with uptake of 
influenza vaccine by comparing determinants in adults and children living in the same 
household. We will be able to make some inference about the similarity or differences of the 
decision making process for these two groups. This understanding is key to improving 
vaccination rates in the general public. Moreover, using confirmed vaccination status as the 
primary outcome represents an improvement over many previous studies that only look at self- 
or parental-reported status, or vaccine intention. 
Viral Interference  
Households are also a useful environment to study transmission of influenza as well as 
other respiratory viruses. It has been frequently observed that seasonal epidemics of influenza 
and other respiratory viruses do not coincide. In particular, rhinovirus (RV) has been observed to 
peak in early fall, while influenza generally peaks during the winter months [56, 57]. Many of 
the basic descriptive epidemiology studies of influenza and other respiratory viruses date to the 
1970’s. For example, Glezen reported that an influenza outbreak appeared to suppress the spread 
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of respiratory syncytial virus (RSV) during the winter of 1975-1976 [2]. These observations have 
been used to suggest that respiratory viruses may interfere with each other, and that this 
phenomenon may be an important factor in terms of the spread of acute respiratory infections.  
The majority of the published research regarding viral interference to date has been from 
hypothesis generating, ecologic studies [2, 11, 58-61]. To illustrate, several investigators in 
Europe have described a delay in the expected peak of pandemic H1N1 during the fall of 2009 
that corresponded temporally with an outbreak of rhinovirus [58-60]. Other studies have 
described this phenomenon based on the observation that RSV epidemics appear to be 
suppressed if the peak does not occur prior to an increase in influenza cases [11, 62]. It is 
hypothesized that the mechanism by which these viruses may interfere with transmission of the 
others is by causing an innate immune response of the infected person [63]. The activated 
immune system of the individual could, in theory, lead to greater protection against subsequent 
infection, and therefore, reduced transmission. Influenza has been shown to illicit and innate 
immune response, as have other viral infections.  
Recently, however, Cowling et al. did explore this hypothesis in greater depth than 
previous studies by focusing on individuals that participated in a randomized vaccine trial. They 
found that children who received trivalent inactivated influenza vaccine (TIV) were more than 4 
times more likely to develop a non-influenza respiratory infection over a 9 month follow up 
period [63]. The authors further note that significant protection against influenza was observed in 
the vaccinated group. Based on this observed protection they hypothesize that the lack of innate 
immune response to influenza infection in the vaccinated children makes these participants more 
susceptible to infection with other respiratory viruses. Importantly, Cowling et al note that there 
were some vaccine failures, however, it is unclear if the authors stratified their results by 
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influenza infection status to examine their hypothesis further. The reasoning behind this decision 
may have been due to the fact that these results are already limited by a small sample size, and 
further stratification was not feasible.  
The previous studies summarized above that have examined viral interference are limited 
in their ability to determine causality. In fact, we are unaware of any studies that have examined 
the impact of other respiratory virus infections on the occurrence of influenza infection at the 
individual level. Understanding factors that affect the dynamics of influenza transmission has 
important implications. The HIVE cohort is uniquely able to address this issue in that it follows 
entire households to determine both vaccination status and the occurrence of acute respiratory 
infection of any severity. We were, therefore able to use results from influenza and non-influenza 
respiratory virus surveillance to conduct a larger-scale analysis of the potential effects of viral 
interference.  
Influenza and RSV are the two respiratory viruses with the most research into immune 
responses in humans. We will, therefore, use these viruses to further exemplify the complicated 
nature by which the innate immune response could lead to viral interaction. Both viruses infect 
epithelial cells in the respiratory tract and are initially recognized by Toll-Like Receptors (TLRs) 
and they both initiate an anti-viral inflammatory response that results in the recruitment of 
natural killer and dendritic cells [64, 65]. These responses are not specific to either virus and 
could explain an antagonistic interaction. There are also, however, important differences in the 
immunology of these infections. Retinoic Acid Inducible Gene I (RIG-I), for example, is an 
essential component of the innate immune response to influenza which induces production of 
type I interferons (IFN) [64]. In human challenge studies influenza viral load and IFN-α both 
peak at the same time post infection and type I IFNs are thought to be key players in limiting the 
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replication of virus. RSV, on the other hand, is not only a poor inducer of IFN-α, but actively 
inhibits its production by blocking the RIG-I signaling pathway [65]. Further work is needed to 
identify the roles of innate immunity in synergistic or antagonistic interactions of respiratory 
viruses, but there is immunologic evidence to support either hypothesis.   
 Understanding viral interference could be important for public health in a number of 
ways. The first is that a better understanding of pathogenesis, and the potential to forecast future 
outbreaks, could lead to better prevention strategies. In addition, if the observations by Cowling 
et al. represent a real phenomenon, then VE estimates from test negative studies could be biased. 
Moreover, vaccination could lead to increased risk of other respiratory infections such as RSV 
which can cause substantial lower respiratory disease in young children [32]. Finally, live 
attenuated influenza vaccines (LAIV) may have reduced effectiveness against specific strains if 
the attenuated vaccine viruses are competing for the same resources and one or two tend to 
replicate in the vaccine recipient and produce protective immune responses at the expense of the 
others. 
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Table 1-1. History of household studies, adapted from Monto et al 1994 
1 Maximum number of households (families) enrolled 
2 Average number of households (families) enrolled 
Study Size 
(Households) 
Start and 
End Date 
Illness 
Reporting 
Respiratory specimen 
collection 
Method for virus 
identification 
Collection of 
blood for 
serology 
Hagerstown, 
MD 
8587 (1815) December 
1921-March 
1924 
Household 
visits every 
6-8 weeks 
None None None 
Baltimore, MD 562 (118)1 1928-1930 Weekly 
phone call 
or postcard 
None None None 
Cleveland 
Family Study 
292 (61)1 1948-1958 Weekly 
home visits 
With illness Serology, Culture Spring and Fall 
New York 
Virus Watch 
180 (40)2 1961-1965 Weekly 
home visits 
From some individuals at 
regular intervals, from 
symptomatic individuals 
and healthy contacts 
Serology, culture Every 6 months 
Seattle Virus 
Watch 
349 (75)1 1965-1970 Weekly 
home visits 
From some individuals at 
regular intervals, from 
symptomatic individuals 
and healthy contacts 
Serology, culture Every 6 months 
Tecumseh, MI 1000 (20)2 1965-1971; 
1976-1981 
Weekly 
phone call 
Home visits during illness Serology, culture Every 6 months 
Houston, TX 355 (97)1  1975-1980 Twice 
weekly 
phone calls 
Home visits during 
illness; occasional 
sampling of healthy 
individuals 
Serology, culture Every 4 months 
for the first year 
of life; pre- and 
post-season 
HIVE Study 1441 (328)1 2010-
present 
Weekly 
phone call 
or email 
Clinic visits during illness RT-PCR Enrollment, pre- 
and post-season 
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Table 1-2. HIVE Study population size and basic demographic information by year for the four years included in this dissertation 
(2010-2011 through 2012-2013 seasons) and site (year four only) 
Season 2010 – 2011 2011 – 2012 2012-2013 2013-2014 
Site UM UM UM HF UM 
Enrolled population - number (households) 1441 (328) 943 (213) 1426 (321) 248 (58) 1049 (232) 
Enrolled Household - Size  (min – max) 4-9 4-9 4-10 4-6 4-9 
Mean Household Size 4.4 4.4 4.4 4.3 4.5 
Age - mean (SD) 21.9 (17.1) 22.9 (17.3) 21.5 (17.1) 24.9 (17.6) 22.8 (17.4) 
Age Category - number (%)      
 0-8 468 (32.5) 301 (31.9) 459 (32.2) 51 (20.6) 308 (29.4) 
 9-17 373 (25.9) 250 (26.5) 376 (26.4) 88 (35.5) 309 (29.5) 
 18-49 542 (37.6) 352 (37.3) 534 (37.4) 90 (36.3) 381 (36.3) 
 50 + 58 (4.0) 40 (4.3) 57 (4.0) 19 (7.7) 51  (4.9) 
     Total Children 841 (58.4) 551 (58.4) 835 (58.6) 139 (56.0) 617 (58.8) 
     Total Adults 600 (41.6) 392 (41.6) 591 (41.4) 109 (43.9) 432 (41.2) 
Sex - number (%)      
Female 728 (50.5) 463 (49.1) 713 (50.0) 135 (54.4) 533 (50.8) 
Male 713 (49.5) 480 (50.9) 713 (50.0) 113 (45.6) 516 (49.2) 
SSP - Mean (SD)   6.8 (1.2) 6.3 (1.3) 6.8 (1.1) 
UM – University of Michigan 
HF – Henry Ford Health System 
SSP – Subjective Social Position, measure on a 9 point scale 
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Chapter 2. Factors associated with vaccine receipt 
 
Background 
Seasonal outbreaks of influenza cause substantial morbidity and mortality each year. 
Influenza vaccine is widely recognized as the first line of defense against infection and is 
moderately effective [66-68]. Beginning in 2010, the Advisory Committee on Immunization 
Practices (ACIP) recommended that all persons over 6 months of age in the United States receive 
an influenza vaccine annually [40]. Despite this essentially universal recommendation, 
nationwide coverage estimates for the 2010-2011 influenza season were well below the Healthy 
People Initiative’s goal of 80% [69] for children (51%) and adults (40%) [70]. Understanding the 
decision-making process regarding influenza vaccination is key to improving coverage in the 
general public.   
Factors associated with vaccine receipt have been extensively studied among healthcare 
personnel (HCP). Previous vaccine receipt, perceived effectiveness, and convenience have all 
been associated with vaccination [5, 6, 10, 46]; with self-protection identified as the primary 
motivation [43]. Recently, vaccine uptake has been studied in specific populations of 
community-dwelling children and adults, such as those at higher risk [9-16]. These studies have 
reported associations linking vaccine uptake with doctor recommendation [4, 9, 49]. Perceived 
risk of influenza, and perceived safety and effectiveness of the vaccine were associated with an 
increased intention to have children vaccinated [3]. Yi and colleagues also found that vaccinated 
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adults had higher perceived risk, underlying high-risk conditions, and reported prior influenza 
vaccine receipt [52].  
The Health Belief Model (HBM) includes five constructs that influence health behaviors: 
perceptions of susceptibility, severity, barriers, and benefits, plus cues to action [71]. Using a 
theoretical framework derived from the HBM, we surveyed adult participants in the Household 
Influenza Vaccine Effectiveness (HIVE) Study. The primary objective was to use this framework 
(Figure 2-1) to examine factors associated with documented influenza vaccine receipt in adults 
and children living in the same household. In addition, we evaluated potential effect modification 
by cues to action, specifically, external motivators such as family and doctor recommendation 
that may spur an individual to get vaccinated.  
Methods 
Participants  
The HIVE study is an ongoing prospective cohort study of households with children 
residing in and around Ann Arbor, MI. Eligibility, recruitment and enrollment procedures have 
been described previously [72, 73]. Briefly, for the study period encompassing the 2010-2011 
influenza season, households with four or more individuals and at least two children were 
contacted beginning in June 2010 and attended enrollment interviews during which adults 
provided written informed consent for themselves and their children; children older than seven 
provided oral assent. In 2010-2011, 328 households and 1441 individuals participated; 602 
(42%) were adults and 839 (58%) were children younger than 18 years. The institutional review 
board at the University of Michigan Medical School approved this study.  
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Predictor variables and potential confounders 
Surveys were adapted from research conducted during the 2009 H1N1 pandemic to 
examine the facilitators and barriers to receipt of the monovalent vaccine [74, 75]. Surveys were 
distributed in the fall of 2010 using online software (Qualtrics, Provo, UT); paper copies were 
available upon request. Adult household members were queried about the factors influencing 
their decisions regarding the receipt of seasonal influenza vaccine for themselves and their 
children. In addition, they reported their perception of the likelihood of specific outcomes of the 
current season’s influenza outbreak including the occurrence of any illness, a severe illness, and 
the impact on the health care system or community (i.e. overcrowded hospitals, school closures). 
Survey question wording and response scales are described in Table 2-1. Covariates significantly 
associated with predictors and the outcome, or previously established associations [3, 4, 8, 49], 
were considered in adjusted statistical models. Age and sex were reported at enrollment, adults 
self-reported education and occupation (including HCP status) and medical conditions 
considered high-risk for complications of influenza [40] were identified by review of medical 
record.  
Individual survey items were grouped into their respective HBM constructs according to 
the theoretical framework (see Table 2-1). Items were rated on either a 5-point Likert-scale 
(Unlikely to Likely) or a 3-level influence scale (not a reason, minor reason, major reason). The 
Likert-scale items were converted to 3-levels so that all items were associated with a similar 
scale of 1 (unlikely or not a reason), 2 (uncertain or minor reason), or 3 (likely or major reason). 
Responses were coded such that higher values of a specific item represented a higher level of the 
corresponding HBM construct, and were reverse coded when necessary (e.g. “I never get 
influenza” was reverse coded to represent higher levels of perceived susceptibility).  Adult 
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responses were assigned to children in households with at least one completed survey based on 
responses to the question “Who decides whether or not children less than 18 years old in your 
household get an influenza vaccine?”  If more than one adult reported involvement, an average 
of the responses was calculated and assigned to each child.  
Individual survey items, or the average for children with multiple adult responses, were 
summed to create scores for each component of the framework (Table 2-1). In order to facilitate 
interpretation, the distribution of each score was examined to determine appropriate cut points 
and categorized accordingly. Perceived barriers and cues to action were split into tertiles and 
perceived benefits, susceptibility, and severity were split at the median value.  
Outcome - Vaccination Status 
The primary outcome was documented receipt of at least one seasonal influenza vaccine 
between August 2010 and March 2011. Documentation was determined by examining the 
medical record and/or the Michigan Care Improvement Registry for evidence of vaccine receipt.  
Statistical Analysis 
Mean response values for individual survey items were calculated by vaccination status, 
and compared using a two-sample t-test. A higher mean response value corresponded to greater 
perceived likelihood of an event or greater importance of that factor in the vaccination decision. 
Framework components were categorized as described and examined in log-binomial regression 
models to estimate the associations between individual components and documented vaccine 
receipt [76]. The lowest category of each factor was used as the referent group. Partially adjusted 
multivariate models controlled for variables that were associated with both vaccination and 
attitudes about vaccine (age, sex, high-risk condition, health care worker status, education). Fully 
adjusted multivariate models considered the influence of all other constructs on the association 
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between each individual construct and vaccine receipt.  All models considered clustering of 
subjects in the same household using robust standard error or “sandwich variance estimates” 
[77]. To evaluate potential effect modification by cues to action we included a product term in 
partially adjusted models; results were subsequently stratified by levels of the effect modifier. 
All statistical analyses were conducted using SAS (release 9.2, SAS Institute) software.  
A P-value <.05 was considered to indicate statistical significance.    
Results 
Characteristics 
Characteristics of the adult survey respondents and the children in their household are 
presented in Table 2-2; 549 (92%) adults from 312 (95%) households completed the fall survey. 
Survey responses for those who reported involvement in the vaccination decision for children 
resulted in knowledge, attitudes, and practices recorded for 778 children (93%).  Documented 
evidence of receipt of at least one dose of 2010-2011 seasonal influenza vaccine was found in 
54% and 66% of adults and children, respectively. Household educational attainment was high, 
85% of adult respondents had graduated from college and 89% of children had at least one parent 
who had graduated from college. Eleven percent of adults and 10% of children had one or more 
medical record confirmed high-risk conditions. Eighteen percent of adults reported that they 
were HCPs, and 24% of children had at least one parent that reported working in health care. 
Factors associated with vaccination 
Among adults with documented receipt of influenza vaccine, the most commonly 
reported major factors influencing the decision to get vaccinated were health care provider 
recommendation (cue to action) (47%), and two “perceived benefit” items: living or working 
with high-risk individuals (44%), and wanting to lower their own risk of disease (90%). Parents 
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reported doctor recommendation (53%) and lowering risk (95%) as major factors in favor of 
vaccinating their children.  
Among unvaccinated adults and parents of unvaccinated children, low perceived 
susceptibility (57% and 51%, respectively) was commonly cited as a major factor influencing the 
vaccination decision. Additionally, concern about vaccine safety was more commonly cited as a 
major factor among parents who chose not to vaccinate (18%) than among those who vaccinated 
their children (3%).  
Survey items were grouped according to the theoretical framework and the mean 
responses presented by vaccination status in Table 2-1. Mean responses to survey items among 
vaccinated adults and parents of vaccinated children were higher, indicating greater influence on 
the vaccination decision, for cues to action such as doctor and family recommendation. Likewise, 
vaccination was associated with higher mean responses for perceived benefits such as lowering 
one’s risk of infection or protecting those at high risk. Vaccinated adults and parents of 
vaccinated children had lower perceptions of barriers such as a belief that the vaccine is 
ineffective or unsafe. 
Health Belief Model Constructs and Vaccination 
In unadjusted models, those reporting higher perceptions of susceptibility, benefits and 
cues to action were significantly more likely to have documented receipt of the 2010-2011 
seasonal influenza vaccine than those reporting the lowest levels (Table 2-3). In addition, 
moderate and high perceived barriers were significantly associated with decreased likelihood of 
vaccine receipt in both adults and children. 
Partially adjusted models that controlled for age, sex, high-risk condition, education, and 
HCP status showed similar results. Significant associations were observed for perceptions of 
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susceptibility, benefits, barriers and cues to action. In fully adjusted models that also controlled 
for the other constructs, the observed associations were attenuated. Nevertheless, after adjusting 
for participant characteristics and shared variance with other HBM components, high levels of 
perceived benefits, susceptibility, and cues to action remained significantly associated with 
increased likelihood of vaccination among adults. Children whose parents reported high levels of 
perceived benefits and severity were more likely to be vaccinated independent of participant 
characteristics and other components. The highest levels of perceived barriers also remained 
independently associated with decreased likelihood of vaccination. The results of unadjusted, 
partially adjusted, and fully adjusted models are presented in Table 2-3. 
Effect Modification 
We evaluated cues to action as a potential modifier of the associations between the other 
framework components and vaccine receipt. Significant effect modification by cues to action (p 
for interaction term < 0.05) was observed for the associations between vaccination and all 
additional factors among both adults and children (Table 2-4) in partially adjusted models.  To 
assess this further, we examined the proportion vaccinated by level of each factor, further 
stratified by cues to action (Figure 2-2). The effects of perceptions of barriers and severity for 
adults, and perceptions of benefits, susceptibility, and severity for children all appeared to be 
modified by cues to action based on the variable slopes of lines connecting data points at each 
level.  
To illustrate, among adults reporting low levels of cues to action, 52% of those with low 
levels of perceived barriers received vaccine compared to 5% vaccinated among those with high 
levels of perceived barriers. In contrast, among the strata with high levels of cues to action, the 
percentage vaccinated did not differ for those with low perceived barriers (69%) versus those 
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with high perceived barriers (64%). In addition, at moderate and high levels of cues to action, 
perceived severity had little or no association with vaccine receipt, while at the lowest level of 
cues to action the proportion vaccinated increased from 24% to 38% with increased perceptions 
of severity.  
Among adults, similar slopes of all lines representing stratified perceptions of 
susceptibility and benefits indicate that the unadjusted effect of those factors may not be 
modified by cues to action. Among parents with low levels of cues to action and low perceived 
susceptibility, 23% of children were vaccinated compared to 67% vaccinated among those with 
high perceived susceptibility. However, at high levels of cues to action, there appears to be no 
association with vaccination (80% and 71% vaccinated among low and high perceived 
susceptibility, respectively). A similar trend was observed for perceived severity in children; the 
strongest associations were among parents with low cues to action.  
In terms of perceived benefits, the greatest change in proportion vaccinated between 
those with low and high perceptions was observed for adults and parents of children with low 
levels of cues to action. Modification of the association between perceived barriers and 
vaccination of children appeared less dramatic than among adults.  
Table 2-4 presents the results of partially adjusted multivariate log-binomial regression 
models stratified by level of cues to action. Among adults, high perceived barriers was 
significantly associated with decreased likelihood of vaccination at low and moderate levels of 
cues to action, but not if cues to action were high. Among children, the effects of perceptions of 
susceptibility, severity, and benefits were all significant among parents with low cues to action, 
but these effects were reduced for those with moderate cues to action and were no longer 
significant with high cues to action.   
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Discussion 
Previous studies of influenza vaccine uptake have focused on HCP [8, 49], young 
children [4, 9], or high-risk individuals [14, 18, 50]. Given the current, nearly universal 
recommendation for seasonal influenza vaccination, understanding factors associated with 
vaccine receipt in community dwelling adults and children of all ages is critical. The HIVE study 
provided a unique opportunity to examine knowledge, attitudes and practices regarding influenza 
prevention strategies in this population in the context of a household. In addition, as a 
prospective cohort study of influenza vaccine effectiveness our study documented influenza 
vaccine receipt using two sources rather than relying on self-report or intent to vaccinate.  
Consistent with findings based on self-reported vaccination or intention, we found that 
perception of benefits, barriers, and cues to action were associated with documented receipt of 
influenza vaccine during the 2010-2011 season [3, 4, 9, 49]. Specifically, we detected a very 
strong association between parental perception of the benefits of vaccination and the decision to 
vaccinate their children. We also observed, among adults who reported a high level of barriers, a 
substantially reduced likelihood of vaccination for both themselves and their children. These 
results indicate that educational campaigns directed at the public may be best served by 
addressing these content areas. Smaller associations were observed for perception of benefits, 
barriers, and cues to action in models that controlled for the other attitudes, suggesting that the 
components of the health belief model had overlapping information. However, significant 
associations remain even after adjustment for the overlap indicating that there are independent 
associations between vaccination and perception of benefits and barriers and cues to action. 
Doctor and family recommendation have been previously shown to influence vaccine 
uptake [4, 9, 49]. We demonstrated not only that these factors were associated with vaccination 
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in adults and their children, but also that the effect of other health belief model constructs were 
modified by cues to action. Specifically, among adults, we found that the reduction in likelihood 
of vaccination due to perceived barriers disappeared at the highest levels of cues to action. In 
other words, it appears that external motivating factors such as doctor or family recommendation 
may be able to overcome the negative influence of concerns about safety or effectiveness on the 
decision to be vaccinated against influenza. This finding is consistent with observations that 
doctor recommendation was associated with parental perceptions of safety [78] and implies that 
intervention strategies that focus on increasing external motivation for adult patients with these 
types of concerns may be particularly effective. In addition, among parents who report low levels 
of cues to action we found that perceptions of susceptibility and benefits were more strongly 
associated with vaccinating their children than among their counterparts with higher levels of 
cues to action. Therefore, targeting parents with public health messages that may increase 
perceptions of susceptibility and severity of influenza, and perceived benefits of vaccine may 
result in better returns in terms of increasing vaccine uptake. 
The influenza vaccine has become much easier to obtain outside of the traditional health 
care delivery system in recent years. As a result, documenting vaccination status is not immune 
to misclassification. However, this outcome is less likely to be misclassified than self or parental 
report or behavioral intention [5, 8, 10, 18, 52, 54, 55, 79]. The HIVE cohort has a high level of 
educational attainment and is predominately white non-hispanic; both are associated with higher 
levels of vaccination [49, 80]. In addition, approximately 60% of the HIVE cohort received 
vaccine during the 2010-2011 season [72]. These demographics characteristics are representative 
of the region from which the population was drawn, nevertheless, our ability to generalize these 
results to external populations may be limited.   
29 
 
The use of a well-established theoretical framework is a major strength of this analysis. 
This particular framework describes the proposed associations between the components of the 
health belief model and influenza vaccination for the current season only. Importantly, these 
attitudes do not exist independently of previous experiences. Rather, they are likely associated 
with vaccination history in interesting and complicated ways. In addition, prior season 
vaccination status is often a major predictor of vaccine receipt in the current season [5, 6, 10, 
46]. As a result, not controlling for prior season vaccination status may lead to biased effect 
estimates. However, the association with prior vaccination may be a feedback loop whereby 
attitudes influence vaccine decision in one year, subsequent experiences with adverse events or 
infection lead to potential changes in those same attitudes which in turn are associated with 
receipt of vaccine in the following year. Because previous experience with vaccination may be 
part of the causal pathway, simply adding it to a regression model might actually increase bias 
instead of reducing it [81]. 
Increasing parental perception of benefits and reducing the perceived barriers associated 
with influenza vaccine may be effective strategies for public health interventions. External 
motivators, such as doctor recommendation, have the potential to modify the effect of various 
factors, which may have important implications for targeted intervention. Confirmation that 
modification of these factors will result in changes in behavior will require longitudinal 
assessments, preferably with multiple years of survey and documented vaccination data in order 
to better address the complicated nature of prior season vaccination.
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Table 2-1. Attitudes toward influenza vaccine, including mean response value and standard deviation of individual survey items which are 
subsequently summed to create HBM constructs. 
   Mean (SD) Response Value 
   Adults Children 
HBM 
Construct 
Item Wording Vaccinated Unvaccinated Vaccinated Unvaccinated 
Cue to action Doctor 
Recommendationa 
My health care provider recommends that I 
get vaccinated 2.3 (0.7)
e 1.7 (0.8) 2.6 (0.6)e 1.8 (0.6) 
 Family 
Recommendationa 
My friends and/or family recommend that I 
get vaccinated 1.8 (0.7)
e 1.5 (0.6) 1.7 (0.6)e 1.4 (0.3) 
 Work providesa My work provides influenza vaccine for all 
employees 1.6 (0.9)
d 1.4 (0.7) -- -- 
Perceived 
Susceptibility 
Susceptible to 
influenzaa, c 
I never get influenza (reverse coded to reflect 
level of susceptibility) 2.9 (0.4)
e 2.4 (0.7) 2.9 (0.3)e 2.5 (0.6) 
 Family illb You or someone in your family or group of 
friends will get sick with influenza 2.7 (0.7) 2.6 (0.6) 2.7 (0.5)
d 2.6 (0.5) 
Perceived 
Severity 
Family Severely Illb You or someone in your family or group of 
friends will get severely sick (require 
hospitalization) with influenza 
1.4 (0.6) 1.4 (0.6) 1.4 (0.6) 1.4 (0.6) 
 Community Affectedb Influenza will disrupt your community 
(example: school closings) 1.6 (0.8) 1.5 (0.8) 1.6 (0.7) 1.6 (0.7) 
 Healthcare System 
Affectedb 
Influenza will disrupt the healthcare system in 
your area (example: overcrowded hospitals) 1.7 (0.8) 1.5 (0.8) 1.7 (0.7)
d 1.5 (0.7) 
Perceived 
Barriers 
Insurancea The influenza vaccine is not covered by my 
insurance/I am uninsured 1.1 (0.3)
d 1.2 (0.5) 1.0 (0.2)d 1.1 (0.4) 
 Ineffectivea I do not think the influenza vaccine works 1.1 (0.4)e 1.7 (0.8) 1.1 (0.3) 1.8 (0.8) 
 Allergic I am allergic to a component of the vaccine 1.0 (0.3) 1.0 (0.1) 1.0 (0.2)d 1.1 (0.4) 
 Unsafea I do not think the influenza vaccine is safe 1.1 (0.3)e 1.5 (0.7) 1.2 (0.4)e 1.7 (0.8) 
Perceived 
Benefits 
Lower Riska I want to lower my risk of getting sick with 
influenza 2.9 (0.4)
e 2.1 (0.9) 3.0 (0.3)e 2.0 (0.8) 
  Live/work with High 
Riska 
I live/work with people at high risk of 
influenza infection 2.1 (0.9)
e 1.6 (0.8) -- -- 
a 3-point scale: Please select whether each of the following is a major reason (3), a minor reason (2), or not a reason at all (1), in your decision about whether 
or not to get an influenza vaccination for yourself [the children in your household] this fall or winter. 
b Originally measured on a scale from 1 (unlikely) to 5 (likely), collapsed to 3 categories: Unlikely (1), Neither likely nor unlikely (2), Likely (3) 
c Item was reverse coded so that higher values reflect higher levels of the HBM construct 
d p < 0.05 
e p < 0.0001 
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Table 2-2. Characteristics of Fall 2010 adult survey respondents and the children in those 312 households 
with at least one adult response. 
  Adults (N = 549)a Children (N = 778)a 
Demographics n % n % 
Female 305 55.6 359 46.1 
Age (years)         
< 9 years -- -- 433 55.7 
9 - 17 years -- -- 345 44.3 
18 – 49 years 495 90.2 -- -- 
50 + years 51 9.8 -- -- 
Race         
White 435 79.2 591 76.0 
Black 18 3.3 42 5.4 
Asian 48 8.7 63 8.1 
Other 48 8.7 82 10.5 
High Risk Condition 62 11.3 79 10.2 
2010-2011 Seasonal Influenza 
Vaccine Receipt 296 53.9 511 65.7 
Educationb         
Less than college graduate 78 14.2 84 10.8 
College Graduate 189 34.4 234 30.1 
Postgraduate Degree 280 51.0 460 59.1 
Occupation         
Health Care Workerc 98 17.9 189 24.3 
Other 450 82.0 589 75.7 
a 91.1 % of adults responded to the fall survey; 92.8% of children lived in a household 
with at least one adult respondent 
b For children this is the highest reported parental education 
c For children this is health care worker status of either parent 
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Table 2-3. Factors associated with receipt of 2010-2011 seasonal influenza vaccine among adults and children, RR and 95% 
Confidence Interval presented for unadjusted and adjusted log-binomial regression models 
A) 
   Adults 
HBM Construct Unadjusted Partially Adjusteda Fully Adjustedb 
Perceived Susceptibility       
Low (Referent) 1.00 -- 1.00 -- 1.00 -- 
High 1.55 1.30-1.85 1.54 1.30-1.83 1.21 1.03-1.42 
Perceived Severity       
Low (Referent) 1.00 -- 1.00 -- 1.00 -- 
High 1.13 0.95-1.34 1.13 0.95-1.33 1.09 0.95-1.27 
Perceived Benefits       
Low (Referent) 1.00 -- 1.00 -- 1.00 -- 
High 1.74 1.45-2.08 1.69 1.42-2.02 1.25 1.04-1.50 
Perceived Barriers       
Low (Referent) 1.00 -- 1.00 -- 1.00 -- 
Moderate 0.40 0.24-0.66 0.69 0.54-0.89 0.83 0.66-1.05 
High 0.12 0.07-0.21 0.29 0.19-0.45 0.38 0.25-0.59 
Cues to Action       
Low (Referent) 1.00 --   1.00 -- 
Medium 2.00 1.62-2.46 2.01 1.62-2.50 1.64 1.31-2.05 
High 2.07 1.63-2.63 2.15 1.68-2.76 1.62 1.25-2.10 
a Adjusted for age, sex, education, health care worker status, and high-risk condition 
b Adjusted for age, sex, education, health care worker status, high-risk condition and other HBM Constructs 
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B)
  Children 
HBM Construct Unadjusted Partially Adjusteda Fully Adjustedb 
Perceived Susceptibility       
Low (Referent) 1.00 -- 1.00 -- 1.00 -- 
High 1.29 1.10-1.53 1.30 1.11-1.53 0.98 0.88-1.10 
Perceived Severity       
Low (Referent) 1.00 -- 1.00 -- 1.00 -- 
High 1.24 1.05-1.46 1.25 1.06-1.46 1.13 1.00-1.27 
Perceived Benefits       
Low (Referent) 1.00 -- 1.00 -- 1.00 -- 
High 6.48 3.82-11.00 6.27 3.72-10.58 4.16 2.28-7.59 
Perceived Barriers       
Low (Referent) 1.00 -- 1.00 -- 1.00 -- 
Moderate 0.67 0.46-0.97 0.67 0.47-0.95 0.77 0.54-1.11 
High 0.33 0.24-0.46 0.32 0.23-0.45 0.58 0.43-0.79 
Cues to Action       
Low (Referent) 1.00 -- 1.00 -- 1.00 -- 
Medium 2.03 1.57-2.64 1.99 1.54-2.56 1.14 0.94-1.38 
High 2.09 1.61-2.72 1.97 1.53-2.55 1.10 0.93-1.31 
a Adjusted for age, sex, education, health care worker status, and high-risk condition 
b Adjusted for age, sex, education, health care worker status, high-risk condition and other HBM Constructs 
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Table 2-4. Factors associated with receipt of 2010-2011 seasonal influenza vaccine among A) adults and B) children, RR and 95% Confidence 
Interval for adjusteda log-binomial regression models stratified by tertiles of Cues to Action Score 
A) 
 Adults 
Cues to Action Low Moderate High p-valueb 
Perceived 
Susceptibility       0.009 
Low 1.00 -- 1.00 -- 1.00 --  
High 1.96 1.28-2.98 1.27 1.03-1.56 1.20 0.93-1.56  
Perceived 
Severity       0.018 
Low 1.00 -- 1.00 -- 1.00 --  
High 1.76 1.13-2.75 1.04 0.86-1.25 0.94 0.73-1.21  
Perceived 
Benefits       < 0.001 
Low 1.00 -- 1.00 -- 1.00 --  
High 2.02 1.38-2.95 1.43 1.15-1.78 0.93 0.67-1.28  
Perceived 
Barriers       0.003 
Low 1.00 -- 1.00 -- 1.00 --  
Moderate 0.50 0.28-0.88 0.95 0.73-1.25 0.95 0.70-1.29  
High 0.11 0.04-0.34 0.41 0.25-0.68 1.03 0.61-1.74  
a Adjusted for age, sex, education, health care worker status, and high-risk condition 
b Reported p-value is for the interaction term of cues to action and each HBM construct from partially adjusted log-binomial regression models 
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B) 
 
 Children 
Cues to Action Low Moderate High p-valueb 
Perceived 
Susceptibility 
      0.001 
Low 1.00 -- 1.00 -- 1.00 --  
High 1.96 1.26-3.05 1.10 0.90-1.35 0.93 0.77-1.12  
Perceived 
Severity       0.001 
Low 1.00 -- 1.00 -- 1.00 --  
High 1.99 1.18-3.36 1.27 1.03-1.56 0.92 0.77-1.09  
Perceived 
Benefits       0.002 
Low 1.00 -- 1.00 -- 1.00 --  
High 10.41 5.15-21.04 2.06 0.96-4.41 3.56 1.48-8.53  
Perceived 
Barriers       < 0.001 
Low 1.00 -- 1.00 -- 1.00 --  
Moderate 0.68 0.34-1.35 0.51 0.20-1.31 0.73 0.47-1.12  
High 0.11 0.05-0.26 0.64 0.42-0.96 0.59 0.40-0.87  
a Adjusted for age, sex, education, health care worker status, and high-risk condition 
b Reported p-value is for the interaction term of cues to action and each HBM construct from partially adjusted log-binomial regression models 
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Figure 2-1. Theoretical Framework describing the association between Health Belief Model Constructs and receipt of Seasonal 
Influenza Vaccine 
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Figure 2-2. Proportion of adults and children receiving seasonal influenza vaccine in 2010-2011 by levels of HBM Construct and Cues to Action 
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Chapter 3. Ecologic trends in respiratory virus detections during two years of HIVE 
study Surveillance 
 
Background 
Many studies, including household studies from the 1960s and 1970s, have described 
seasonal trends in the circulation of respiratory viruses, particularly in the United States and 
other temperate regions with a distinct winter [56, 57]. In these regions, there are relatively small 
variations in the timing of outbreaks from year to year; however, the generally held maxim is 
that rhinovirus (RV) peaks in the early fall just after schools open, and both influenza and RSV 
follow, with a peak in the winter [39, 72]. Recently, the importance of coronavirus as an 
etiologic agent of respiratory illness has been recognized [82]. The seasonality of coronavirus is 
frequently described by peak circulation just prior to, or concurrent with, the influenza peak.  
These ecologic trends in viral incidence, and similar observations from Scandinavian 
countries, have been used to postulate a phenomenon that is frequently termed ‘viral 
interference’. In Sweden and Norway, where nationwide surveillance systems are often quite 
good, several studies have emerged from examining the visual trends in virus circulation. 
Anestad and colleagues, for example, reported on a number of seasons of RSV and influenza 
transmission beginning in 1974-1975 and continuing through the 1980-1981 season [11]. The 
authors noted that in years when RSV did not peak prior to the start of the influenza outbreak 
that the RSV epidemics were smaller and without a substantial peak [11]. During the same 
period, Glezen and colleagues were recruiting infants and their families into the Houston Family 
Study [2]. Reports from Houston during the 1976-1977 season are very similar to those from 
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Norway in that RSV epidemics that peaked before widespread circulation of influenza tended to 
be larger than those that peaked after the start of the local influenza season [2, 31].  
More recently, during the 2009 pandemic, the Norwegian researchers observed that the 
outbreak of pandemic influenza A/H1N1 virus did not appear to take off as quickly as expected. 
In this observational study, the pandemic virus did not spread widely until the weekly number of 
rhinovirus positive cases started to decline [58, 83, 84]. Similar observations were reported in 
France and Sweden [59, 60]. 
These studies have contributed immensely to our understanding of respiratory illness in 
the community. However they describe visual trends in surveillance data, generally in 
association with seeking medical care, and lack any sort of statistical evaluation. Many of these 
studies are comparing actual epidemics – which could vary based on a number of different 
factors – to an expected, counterfactual outbreak, based either on data from different countries or 
from existing knowledge about local trends in respiratory illness from past seasonal epidemics. 
The extent and timing of each respiratory virus outbreak, however, can vary considerably by 
both geography and season. In this analysis, we used data from two years of the Household 
Influenza Vaccine Effectiveness (HIVE) Study to evaluate ecologic trends in virus specific 
incidence. This design of this prospective cohort study provides a unique opportunity to assess 
trends of multiple respiratory viruses within a single study population. We conducted a time-
series analysis based on the methods described in Rekart et al [85] to assess if weekly incidence 
of one virus can be used to predict incidence of another virus within their respective season with 
the ultimate goal of describing viral interaction among four of the most common viral agents 
associated with acute respiratory illness (ARI): rhinovirus, coronavirus, influenza, and RSV. 
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Using these methods we aimed to characterize the ecological patterns of correlation to inform 
future studies at an individual level.  
Methods 
Study Years and population 
We chose to examine years one and three of the HIVE study based on the comparability 
of the study size and the timing and duration of ARI surveillance [37, 38]. Specifically, during 
the 2010–2011 (year one) and 2012–2013 (year three) seasons households were enrolled during 
the summer months, and ARI surveillance was conducted from October through early May (year 
one, n=1441, 30 weeks surveillance; year three, n=1426, 32 weeks surveillance). Year two was 
excluded from this analysis because surveillance did not begin until December 2011, and likely 
did not cover the peak periods of rhinovirus or coronavirus transmission. Each year was analyzed 
separately. 
ARI Surveillance and detection of respiratory viruses 
 Methods of ARI surveillance has been described elsewhere. Briefly, participating 
households were contacted weekly by email or phone and asked to report any ARI of less than 7 
days duration with two or more of the following symptoms: cough, fever or feverishness, body 
aches, chills, nasal congestion, headache, or sore throat. Throat and nasal swab specimens were 
collected and tested for influenza A and B and 11 additional respiratory viruses. The ABI 7500 
RT-PCR instrument was used along with primers and probes developed by CDC. 
Quantifying virus specific data 
To get a better understanding of our ability to detect virus-specific interference we first 
sought to quantify the most commonly detected virus data from the two most comparable 
seasons of ARI surveillance in the HIVE Study. At the individual level, we compared the total 
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number of virus detections, co-detections with other respiratory viruses, detections during a 
previous ARI, and repeated detections. At the ecologic level, we calculated virus specific 
incidences by dividing the number of weekly cases by the at-risk population. Weekly cases were 
removed from the at risk population the week after virus detection for that specific virus and 
were not considered at risk for the remainder of the surveillance period. 
Time series analysis 
We used weekly time-series data for the incidence of rhinovirus, coronavirus, influenza A 
and B, and Respiratory Syncytial Virus in the HIVE Study to investigate the cross-correlation of 
their temporal trends using the cross-correlation function method [86]. First, we used the R 
package forecast to estimate the best fit of an autoregressive integrated moving averages 
(ARIMA) model, with or without a seasonal component, separately for each of the virus-specific 
incidences in each year of surveillance. This function finds the ARIMA model that minimizes 
the Akaike Information Criterion (AIC). We used the specified models as a starting point and 
systematically varied the autoregressive (AR) and moving average (MA) orders. We then plotted 
the residuals and examined autocorrelation function (ACF) plots. If two models produced AIC 
values that did not differ substantially (i.e. less than two) [87] we chose the model that produced 
residuals with no visual evidence of trend and no significant auto-correlations. In order to 
account for the fact that two viruses may have common trends over time that are unrelated to 
their interactions we then filtered (pre-whitened) the virus specific incidence data [88]. To do 
this we used the best-fit time series model coefficients for one virus (virus x) to transform the 
incidence data of the other virus (virus y) in each pair. We then compared the cross-correlation 
function plots between the residuals of the time series model for virus x and the corresponding 
filtered virus y values to identify lags with significant cross correlation [89, 90]. Finally, we 
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performed Granger causality tests using the lag with the strongest correlation identified by 
examining the cross-correlation plots of virus x and pre-whitened virus y data [91]. Granger 
causality tests are regression models where, in this case, virus y is the dependent variable and 
lagged values of virus x and virus y are the predictors. Statistical significance is based on the F-
Test. A p-value less than 0.05 was used to determine statistical significance. All analyses were 
conducted using the R statistical software version 3.1.1. 
Results 
Virus specific data 
Rhinovirus was the most commonly detected virus during both surveillance seasons (190 
detections among 165 individuals in year one, 263 detections in 206 individuals during year 
three). In year one, similar proportions (approximately 20-25%) of all four viruses were detected 
at the same time as another respiratory virus (Table 3-1a). In year three, 44% of RSV detections 
were in concert with another virus (Table 3-1b). Among ARI with laboratory confirmed virus 
detection, rhinoviruses were also the most commonly detected virus during a previous ARI 
(Figure 3-1). Rhinoviruses (11% in year one, 23% in year three) and coronaviruses (6% in year 
one, 11% in year three) were the most likely to be detected in multiple ARI in the same 
individual (Table 3-2).  
Weekly viral incidence rates 
Weekly rhinovirus incidence peaked at approximately 14.5 cases per 1000 individuals in 
October of year one and 15.2 case per 1000 individuals in mid-November of year three. Weekly 
coronavirus incidence reached its apex of 17.6 per 1000 in January of year one and 16.0 per 1000 
in January of year three. Peak weekly influenza incidence varied substantially by season from 
13.8 in February of year one to 7.8 per 1000 in December of year three. Weekly RSV incidence 
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reached 7.8 per 1000 in late February during year one and 11.8 per 1000 in December of year 
three. In both years the highest weekly incidence rate is attributed to coronaviruses, followed by 
rhinoviruses, influenza and RSV (Figure 3-2a and 3-2b).  
Rhinovirus and Coronavirus 
Plots of the cross-correlation function and statistical significance of Granger causality 
tests are presented for all virus pairs for year one (Figure 3-3a) and year three (Figure 3-3b), 
respectively. In year one we observed no significant correlations between rhinovirus ARIMA 
model residuals and pre-whitened coronavirus data. There were, however, significant 
correlations at ten and eight weeks when rhinovirus data was filtered to the coronavirus model 
residuals. Granger causality tests suggest that coronavirus predicts rhinovirus regardless of 
whether filtering was done with respect to rhinovirus (p = 0.005) or coronavirus (p = 0.045) at a 
lag of 8 weeks. In year three we observed significant negative correlations between rhinovirus 
and coronaviruses at a lag of three weeks, Granger-causality tests suggested that coronavirus 
predicted rhinovirus at this lag (p=0.039). 
Rhinovirus and Influenza 
During the first year of study there were no significant cross-correlations between 
rhinovirus and influenza regardless of which virus was used to pre-whiten the time-series data. In 
year three, however, rhinovirus and pre-whitened influenza incidence were positively correlated 
at a lag of nine weeks. Additionally, a negative correlation was observed at three weeks when 
comparing rhinovirus model residuals to pre-whitened influenza and at eight weeks when 
comparing influenza model residuals to pre-whitened rhinovirus. Granger tests at all of the lags 
above were non-significant. 
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Rhinovirus and RSV 
There were no significant cross-correlations between rhinovirus and RSV regardless of 
which virus was used to filter the data in year one, though a borderline negative correlation was 
observed at a lag of two weeks. Granger test results were significant for rhinovirus predicting 
RSV incidence at this borderline lag (p= 0.047). No significant cross correlations were observed 
between rhinovirus and RSV in year three. 
Coronavirus and Influenza 
 We observed significant positive correlation between coronavirus time-series model 
residuals and pre-whitened influenza at lags of one and five weeks in year one. There was a 
corresponding significant positive correlation at one week and a significant negative correlation 
at eight weeks between influenza model residuals and filtered coronavirus data. Significant 
granger tests were observed for coronavirus and influenza at a lag of one week (p = 0.004). 
Filtered coronavirus data was also able to predict influenza (p=0.006). In year three, coronavirus 
model residuals and pre-whitened influenza incidence were positively correlated at a lag of zero 
and negatively cross-correlated at a lag of nine. Granger tests were significant for influenza and 
coronavirus regardless of which virus was pre whitened (p = 0.011 for filtered influenza, and 
p=0.0009 for filtered coronavirus), 
Coronavirus and RSV 
 During the first year of study, coronavirus and RSV were correlated at a lag of five weeks 
regardless of which virus was filtered. Significant granger tests for this lag indicate that 
coronavirus predicted RSV (p=0.006). RSV also predicted filtered coronavirus incidence 
(p=0.011). In the third year of study, coronavirus and RSV were significantly cross-correlated at 
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lags of zero, six and seven weeks. Granger tests were not significant for any of these 
associations. 
Influenza and RSV 
In year one, influenza and filtered RSV incidence were negatively cross-correlated at 
both three and six weeks; the correlation at six weeks was slightly stronger. Similarly, RSV and 
pre-whitened influenza data were significantly correlated at zero and one weeks. Granger 
causality tests for the association between influenza and RSV were statistically significant in 
both directions. Influenza residuals and RSV had borderline significant cross-correlations at 
three weeks and nine weeks; the three week lag was significant when influenza was filtered with 
respect to RSV model residuals. Granger causality tests were significant for the association 
between filtered influenza and RSV model residuals (p=0.047). 
Discussion 
We analyzed trends in weekly incidence of four common respiratory viruses from 
surveillance of an ongoing prospective cohort study. We found evidence that viral incidences 
were correlated at the ecologic level, but that these associations varied with respect to the timing 
of the individual outbreaks and across study years. Specifically, we were able to demonstrate 
significant correlation between the incidence of coronavirus and the three other respiratory 
viruses examined, and between influenza and RSV in both study years. However, we found no 
correlation between rhinovirus and RSV in either year. Further, using Granger causality tests, we 
showed that coronavirus could predict influenza, RSV and rhinovirus in year one and influenza 
incidence predicted coronavirus in year three. These results shed light on the predictive ability of 
virus specific incidence on subsequent viral outbreaks within the same season. 
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Additionally, we found similar proportions of co-detection among the four most 
frequently detected viruses in year one and slightly larger proportion of co-detections in year 
three for RSV. Duration of viral shedding can complicate the analysis of co-detection data as 
some viruses (e.g. adenovirus, bocavirus) persist much longer than others [92, 93]. The 
proportion of co-detections was comparable to those reported previously [39, 92]. We also 
sought to quantify the number of virus detections from a prior illness and found that rhinovirus 
was much more common than the others to be a preceding virus. This finding may likely be 
attributed to the timing of the outbreaks as the rhinovirus outbreak is the first to occur and 
detections of coronavirus, which was the second virus to begin spreading, were the second most 
frequently detected virus from a previous ARI.  
 The HIVE study provided unique advantages in that it is a prospective cohort study of 
more than 1400 individuals in which households with children were contacted weekly to 
determine the occurrence of acute respiratory illness. Respiratory specimens were then collected 
from those individuals meeting a case definition intended to capture illnesses of any severity.  
We were able to use data from two years of the HIVE study which consisted of comparable 
study populations and duration of surveillance. Further, detection of respiratory viruses by RT-
PCR is a sensitive and specific laboratory assay and is considered the gold standard for 
laboratory confirmation of the respiratory viruses examined in this study [94, 95]. However, the 
ability to detect virus declines as the time from illness onset to specimen collection increases and 
is associated with age [95].  
Importantly, the methods we used for determining weekly viral incidence may lead to 
under or over estimates of the actual weekly incidence. First, we only collect specimens from 
individuals with symptomatic illness. The relative contribution of asymptomatic infections 
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differs by virus and age but may account for up to 33% of influenza infections [96] and 20% of 
rhinovirus infections [97]. In addition, under-reporting of ARI could lead to an underestimate of 
viral incidence, and may be more common among illnesses caused by viruses that are associated 
with more mild disease. In contrast, after the first detection of a virus the individual was no 
longer considered to be a part of the at risk population for calculation of the subsequent weekly 
incidence of that virus. Depletion of susceptible population in this manner is likely to 
overestimate weekly incidence. This is particularly true for calculations in the later part of the 
season and among those viral diseases where repeat infections are common, such as rhinovirus.  
  Using methods that are generally applied to economic analyses, we were able to 
statistically evaluate the correlations between respiratory viruses that had previously been 
described only as visual trends [2, 11, 58, 60, 83, 84, 98]. However, we also found that these 
correlations are inconsistent by virus type and season. Notably, interpreting these results is 
difficult due to the fact that the associations we observed were between ARIMA model residuals 
and filtered incidence data. It is, therefore, important to be cautious when attempting to interpret 
the lag and direction of the significant cross-correlations. Many of the previous studies were 
based on year-round surveillance of illnesses requiring medical attention. The current study has 
expanded on previous work by including respiratory specimens from illnesses of any severity. 
However, these data represent two years that had to be analyzed separately and compared. It is 
also possible that past seasons may predict future seasons within the same virus; longer time 
series (on the order of five years) can help resolve this question. Data for the 2011-2012 season 
would be helpful in answering some of these questions but are limited in that the duration of 
surveillance was much shorter (23 weeks) and was begun in December, therefore missing the 
rhinovirus peak.  
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While the correlations and Granger causality tests between coronavirus and either 
influenza or RSV were relatively straightforward, the association between influenza and RSV 
was not. In year one, for example, there was bidirectional significance of the Granger causality 
test may be indicative of a feedback system.  Different methods are likely to be required to clear 
up these results given the limitations of Granger causality tests. Specifically, Granger causality 
assumes that there is separability in the two time series. An ecologic causality test for dynamical 
systems has been proposed but was not applied in this analysis [99]. Moreover, in year three the 
peak of the influenza, coronavirus and RSV epidemics occurred almost simultaneously. This 
may explain the lack of statistically significant ecologic causation that was observed in that year. 
Finally, virus interactions are likely more complex than just pairwise associations and an 
approach that can account for more than two time series could also be enlightening. Importantly, 
any of the proposed approaches would still describe ecologic causality, which does not imply 
epidemiologic causality. These methods are useful for examining if prediction of one time series 
is better if you include information about another time series, but they do not suggest that an 
increase in incidence of one virus causes an increase in another.  
Data on relative humidity and air temperature, two factors that are known to be 
associated with respiratory virus transmission [100-103], are not included in these models. 
Similarly we do not account for individual level characteristics such as influenza vaccination or 
prior infection. Additionally, changes in social mixing patterns, such as school openings or 
closings, may influence the timing of respiratory virus outbreaks and are not accounted for in this 
analysis. We also combined viruses in ways that may be hiding important ecologic trends that 
warrant consideration. For example influenza A (two subtypes) and influenza B (two lineages) 
may in fact circulate at different times and the same is true for the four types of coronavirus 
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include in our assay. Determining if circulation of influenza A can predict subsequent circulation 
of influenza B, in particular, may be of interest but likely requires more cases than were detected 
during either year of HIVE Study surveillance.  
In an effort to improve the estimates of weekly incidence we also fit SIR/SIRS 
compartmental models with a system ordinary differential equations (ODEs) and estimated 
transmission parameters using a least squares approach. This approach allowed us to estimate the 
weekly incidence without depleting the at risk population in addition to estimating parameters 
such as the rate of returning to susceptibility.  However it also had a limited utility to the time 
series analysis because the weekly variations in incidence were smoothed to a degree that was 
unrealistic. Much of the variability that could have been useful to predict future incidence of a 
different virus was washed out in the process. We, therefore, conducted the time series analysis 
using the raw weekly incidence data. For future analyses we propose that a stochastic 
compartmental model that can account for the random variation in the weekly incidence data 
may be the most effective strategy. 
 Understanding the pathogenesis of respiratory viruses may help guide prevention 
strategies. We contribute to this understanding by demonstrating that the weekly incidences of 
respiratory viruses, particularly coronavirus, influenza and RSV, are related. However, they are 
likely related via an extensive multifactorial process that is not fully captured by the data 
available from this study. These data and future studies that specifically address some of the 
limitations of this analysis could be helpful in terms of forecasting future epidemics and 
describing the phenomenon of viral interference. We believe that one potential direction for 
future studies is to look at the larger picture and take into account the more distal factors 
associated with viral incidence, principally ambient air temperature and relative humidity. 
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Additionally, however, it may be instructive to focus more specifically by examining trends in 
incidence of type and subtype within the same virus.  
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Table 3-1. Number of detections and co-detections by virus during ARI Surveillance in A) year 
one (2010-2011) and B) year three (2012-2013) of the HIVE Study 
A) 
2010-2011 
  Rhinovirus Coronavirus Influenza RSV 
 
190 151 130 57 
Rhinovirus   7 10 5 
Coronavirus 7 
 
11 2 
Influenza 10 11 
 
4 
RSV 5 2 4 
 Paraflu 9 1 1 1 
HMPV 2 8 6 1 
Adeno 9 1 4 1 
Co-detection 22.1% 19.9% 27.7% 24.6% 
      
B) 
2012-2013 
  Rhinovirus Coronavirus Influenza RSV 
 
263 202 116 86 
Rhinovirus 
 
20 7 7 
Coronavirus 20 
 
6 13 
Influenza 7 6 
 
7 
RSV 7 13 7 
 Paraflu 10 3 0 1 
HMPV 16 6 3 3 
Adeno 22 10 5 7 
Co-detection 31.2% 28.7% 24.1% 44.2% 
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Figure 3-1. Virus detection during current illness by virus detection in prior illness during in A) 
year one (2010-2011) and B) year three (2012-2013) of the HIVE Study 
A) 
Current 
Virus Prior Virus 
 2010-2011 
 
RV COV Flu RSV 
RV 41% 17% 12% 5% 
COV 45% 14% 7% 14% 
Flu 34% 34% 10% 4% 
RSV 31% 31% 25% 6% 
Paraflu 75% 17% 0% 0% 
HMPV 53% 5% 5% 21% 
ADV 62% 8% 0% 8% 
     
     
 
B) 
 
2012-2013 
 
RV COV Flu RSV 
RV 31% 30% 4% 10% 
COV 32% 14% 8% 9% 
Flu 30% 20% 10% 10% 
RSV 32% 24% 3% 5% 
Paraflu 82% 9% 0% 0% 
HMPV 31% 25% 6% 19% 
ADV 38% 18% 6% 6% 
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Table 3-2. Single and multiple detections of viruses in individuals with ARI during years one (2010-
2011) and three (2012-2013) of HIVE Study surveillance 
  2010-2011 2012-2013 
  n % n % 
Rhinovirus 165 
 
206 
 1 147 89.1% 159 77.2% 
2+ 18 10.9% 47 22.8% 
Coronavirus 143 
 
179 
 1 135 94.4% 160 89.4% 
2+ 8 5.6% 19 10.6% 
Influenza 125 
 
111 
 1 120 96.0% 106 95.5% 
2+ 5 4.0% 5 4.5% 
Respiratory Syncytial Virus 56 
 
84 
 1 55 98.2% 82 97.6% 
2+ 1 1.8% 2 2.4% 
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Figure 3-2. Weekly incidence of respiratory virus detections during in A) year one (2010-2011) 
and B) year three (2012-2013) of the HIVE Study 
A) 
 
B) 
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Figure 3-3. Cross-correlation function plots and Granger Causality test results between time-
series residuals and pre-whitened incidence data among four virus pairs in A) year one (2010-
2011) and B) year three (2012-2013) of the HIVE Study 
A) 
 
* Granger Causality test p < 0.05 
** Granger Causality test p < 0.001 
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B) 
 
* Granger Causality test p < 0.05 
** Granger Causality test p < 0.001 
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Chapter 4. Risk of influenza and previous ARI 
 
Background 
Acute respiratory illnesses (ARI), including those caused by influenza and other 
respiratory viruses, are a major source of morbidity and workplace productivity loss in developed 
countries. Much of our current understanding of these illnesses, and the viral agents that cause 
them, originate in the descriptive epidemiologic studies conducted during the 1970’s. The studies 
of this era produced great insights in to the pathogenesis, transmission, and seasonality of 
respiratory viruses [23, 25, 27, 29]. In the northern hemisphere, for example, rhinovirus has been 
observed to peak in early fall while influenza and respiratory syncytial virus (RSV) have 
generally peaked during the winter months. However, the peak incidence of multiple viruses can 
coincide as was observed during the winter of 1975-1976 when an influenza outbreak occurred at 
the same time as an RSV outbreak and the former appeared to reduce transmission of the latter 
[2]. This observation, in conjunction with those derived primarily from examining ecologic 
trends in infection incidence, have led investigators to hypothesize that common respiratory 
viruses compete with each other. Further there have been suggestions that this phenomenon may 
explain differences in the timing of peak infection risk [11]. Generating a better understanding of 
the potential interactions between the viral agents that cause respiratory illnesses can provide 
novel and valuable insights into the pathogenesis of ARI. 
A major advancement in the field was the advent of nucleic acid amplification 
technologies, such as real-time polymerase chain reaction (RT-PCR). With this technology 
58 
 
identifying the viruses that cause respiratory illnesses has become much more common. Recent 
prospective studies of ARI, using these assays, have identified viruses as the etiologic agent of 
interest in upwards of two-thirds of all illnesses [39, 104]. In addition, co-infection is common, 
particularly among younger children, but appears to be agent specific [39, 92]. The ability to 
identify viral agents of etiologic relevance can shed new light on issues of viral interference 
previously observed at the ecologic level. Unlike the well-studied interaction between viral and 
bacterial infections (e.g. Influenza and Streptococcus pneumoniae) [105-107], fewer studies have 
suggested an interaction between respiratory viruses and have hypothesized non-specific 
immunity as the driving force.[11, 12, 60, 104, 108] Many of these studies have limited ability to 
make inferences as they have examined ecological trends [11], or have been unable to adjust for 
individual factors such as age group [104]. 
One of the few studies to examine this phenomenon on an individual basis was an 
analysis of data from a randomized trial of seasonal influenza vaccine in children from Hong 
Kong.[12] The data from this clinical trial found that children in the treatment group (i.e. 
vaccinated children) were at much higher risk, nearly four times higher, of experiencing non-
influenza respiratory infections compared to those who received placebo. The authors 
hypothesize that short-term, innate immunity conferred by influenza infection was absent in 
vaccinated individuals, and, therefore that they were more susceptible to infections with other 
viruses [12]. 
No increase in risk of non-influenza respiratory virus infections for vaccinated 
individuals was found in data collected for an observational study of medically attended illnesses 
from the Marshfield Clinic in Wisconsin.[13] In this study the authors were unable to detect any 
association between influenza vaccination and non-influenza respiratory infection. The primary 
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objective of this study was to investigate sources of bias in the test-negative design, but these 
data were also used to make inferences about viral interference or, as the case may be, a lack 
thereof. Importantly, repeated acute respiratory illness was not a common occurrence in the 
paper by Cowling so the authors were not able to conduct a longitudinal analysis of non-
influenza infection and subsequent risk of influenza or vice versa. Similarly, while individuals 
could enroll multiple times in the Marshfield study, it was an extremely rare occurrence.[12, 13] 
The Household Influenza Vaccine Effectiveness (HIVE) study is an ongoing, prospective 
cohort study of ARI in households with children in and around Ann Arbor, MI. ARI are reported 
on a weekly basis and many individuals have more than one occurrence illness during the 
surveillance period. The design of this study allows us to estimate potential respiratory viral 
interference over several years of study. Given the limited number of studies that have evaluated 
or hypothesized viral interference on an individual basis we have few options for studies to serve 
as a comparison. Therefore, we opted to take a novel approach to this question by evaluating the 
risk of influenza among those who experienced an ARI prior to their current illness compared to 
those who did not.  
Methods 
HIVE Study 
Beginning in 2010, households with at least four individuals and at least two children (< 
18 years old) residing at the same address were enrolled and followed for the occurrence of 
respiratory illness during periods of peak ARI activity.  Each year the cohort of households was 
derived from persons who had selected a primary health care provider from within the University 
of Michigan Health System (UMHS). Households that participated in previous years, and 
remained eligible, were preferentially targeted for enrollment in an attempt to create a 
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longitudinal cohort.  Adult household members provided written informed consent for 
participation and medical record review for themselves and their children; children aged 7-17 
years also provided oral assent. All study contacts with participants, including enrollment and 
illness visits, were carried out at the research study site at the University of Michigan, School of 
Public Health (UM-SPH).   The study was approved by the institutional review board at the UM 
Medical School.   
Surveillance activities 
Surveillance activities for years one through three have been described elsewhere, and 
remained consistent for the fourth year of study [39]. Briefly, during the first, third, and fourth 
study years, households were enrolled during the summer months and respiratory illness 
surveillance was carried out from October through late April or early May; in the second study 
year (2011-2012 season), enrollment was delayed until the fall months and surveillance was 
initiated in December.  Households were contacted weekly with reminders to report all ARIs 
defined by 2 or more of the following symptoms: cough, fever or feverishness, nasal congestion, 
chills, headache, body aches, or sore throat. The case definition was intentionally designed to be 
broad which permitted the inclusion of symptomatic respiratory illnesses of any severity. 
Participants reported illnesses to research staff who determined eligibility; those with an eligible 
ARI attended a specimen collection visit within 7 days of onset and had a combined throat and 
nasal swab (or nasal swab only in children age <3 years) collected for identification of 
respiratory viruses.  If illnesses were reported and the onset day was within 14 days of a prior 
illness, a new instance of fever/feverishness was used to identify a new illness. 
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Previous ARI definitions 
We created dichotomous variables for each illness to indicate a history of a) previous 
ARI at any point during the surveillance period for the given study year or b) a previous ARI 
with illness onset ≤ 28 days before the onset of the current illness. We also created a categorical 
variable with the cumulative number of previous ARI characterized as none, one, or two or more. 
Potential confounders 
To account for seasonality of influenza infections we modeled calendar time as the 
absolute value of the difference, in weeks, between the onset of illness and the peak of influenza 
transmission for that surveillance period. This approach is assumes that the risk of influenza 
varies linearly, and at the same rate of change, both before and after the epidemic peak. Influenza 
vaccination is included in multivariable models because of a clear association with the outcome 
of interest, and because of evidence of an association from the literature [Cowling] and because 
vaccination as associated with reporting ARI during year three (2012-2013) of the HIVE study.  
In addition age category and high-risk status (as defined by evidence of ACIP identified health 
conditions in the medical record) are also included in adjusted models as potential confounders. 
Outcome 
We estimated the association between the predictors described above and influenza 
infection status, which was determined by real-time reverse transcriptase polymerase chain 
reaction (RT-PCR). Throat and/or nasal swab specimens were collected by trained research 
assistants and processed for influenza and eleven other common respiratory viruses using the 
ABI 7500 RT-PCR system platform (Life Technologies).   RNA was extracted from specimens 
for influenza testing using the Qiagen QIAamp Viral RNA Mini Kit, and DNA/RNA for 
additional respiratory virus testing using the Qiagen QIAamp MinElute Virus Vacuum Kit using 
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the accompanying vacuum manifold protocols.  All laboratory testing was performed in the 
investigators’ respiratory virus laboratory at UM-SPH.   
Statistical analysis 
Participant characteristics were examined for each study year by number of ARI reported 
(none, one, and two or more). We then examined the effect of time since previous illness by 
plotting the risk of influenza at two week intervals to look for visual evidence of a trend.  The 
unadjusted relative risk of influenza was calculated for those with some previous experience with 
ARI using various definitions as described above (any ARI, ARI ≤ 28 days prior, cumulative 
ARI). In all unadjusted analyses illnesses are the unit of examination; those with a previous ARI 
were compared to those with no history of ARI using a chi-squared test. Subsequently, we 
conducted a time to event analysis using time-dependent Cox proportional hazards model where 
the outcome was time from the beginning of surveillance until influenza infection and prior ARI 
included as a time varying covariate. This approach allowed us to account for clustering at the 
individual and household level, and to control for potential confounders.  
Finally, we fit an unconditional multi-state model using an illness-death approach; state 
transitions are described in Figure 4-1. This event history framework consisted of three states, 
where influenza infection was the final (absorbing) state and individuals were able to progress 
directly from either a healthy state or via an intermediate route (any previous ARI) [109-111]. 
For this analysis we assumed a Markovian process in which the transition intensity does not 
depend on factors other than the previously occupied state [110]. A major advantage of the 
multi-state model is that the hazard for each transition can be interpreted relative to the others.  
In addition to these primary analyses we conducted a secondary analysis to directly 
address the observations of Cowling et al [63], indicating that vaccinated individuals were at 
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higher risk of non-influenza respiratory virus infection. We fit a logistic regression model to 
estimate the odds of receiving influenza vaccine amongst those who had an ARI with detection 
of a non-influenza respiratory virus at any point during the surveillance period compared to those 
without detection of another virus. Multivariate models were adjusted for age category, high risk 
status as previously defined, and detection of influenza. 
All analyses were conducted with R (3.1.1) statistical software. Statistical significance 
was determined by a p-value less than 0.05 and 95% confidence intervals that did not include the 
value corresponding to the null hypothesis.  
  
Results 
Characteristics of individuals with single and multiple ARI 
During years one (2010-2011), three (2011-2012) and four (2013-2014) nearly 40% of 
individuals that reported any ARI during the surveillance period had multiple illness. In the 
shorter surveillance period during year 2 (2011-2012), 19% of participants with any ARI had 
more than one illness. Each year children 5-11 and adults 18-49 were the age groups most likely 
to have one illness, however, the proportion of individuals in the less than five age group 
increased as the number of illnesses increased during each study year. To illustrate, in year one, 
12% of those without any illness were children less than five years, while 19% and 27% of those 
with one and two or more illnesses, respectively, belonged to this age group. This trend was 
observed during each of the four years of study. Individuals with medical record confirmed high-
risk underlying conditions as defined by the ACIP were no more likely to experience multiple 
ARI that those without high-risk conditions. The proportion of individuals who received an 
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influenza vaccine were also relatively consistent among those with one compared to those with 
multiple illnesses (Table 4-1). 
Risk of influenza by time since prior ARI 
In year one the risk of influenza increased dramatically, compared to those with no prior 
ARI, for those that had a previous ARI onset within two weeks of their current illness. As the 
length of time between illnesses increased in year one the risk of influenza decreased steadily 
until more than eight weeks from the previous illness when the risk again increased. This 
observation was not consistent in the subsequent years of study. In years two and four there was 
an initial decline in risk followed by a rise at over four weeks from the previous illness. In year 
three, risk remained relatively stable until after two-four weeks from the previous illness at 
which point it began to increase slightly. The only consistent trend observed during three of the 
four study years in regards to time since previous ARI was that after approximately four to six 
weeks from the previous illness the risk of influenza began to rise (Figure 4-2). 
Relative Risk of influenza using various definitions of previous ARI 
We examined the unadjusted risk of influenza using various definitions for prior ARI 
exposure, in all analyses the comparison group was those who had no experience with the ARI 
exposure of interest. We observed borderline statistically significant increases in risk of 
influenza after any previous ARI in year one, however, no evidence of an association was 
observed in the following years of surveillance and point estimates both above (suggesting 
increased risk) and below (suggesting decreased risk) one were observed.  
Upon evaluating the risk of influenza for those with a previous ARI within 28 days of the 
current illness we again found no evidence of an association. Further, the point estimates of 
relative risk varied inconsistently when compared to any previous ARI depending on the year of 
65 
 
study. Similarly, no clear association was identified for those who had a greater cumulative 
number of previous ARI as the relative risk was higher in year one, remained relatively 
consistent in year three, and decreased in both year two and year four (Table 4-3).   
Cox proportional hazard models 
In Cox proportional hazards models we again found no evidence of an association 
between the hazard of influenza infection and either any previous ARI or a previous ARI that 
had occurred within 28 days (Table 4-3). During three of the four years (years one through three) 
the point estimates for unadjusted models with any previous ARI as the exposure of interest were 
greater than one suggesting an increased risk of influenza. However, in fully adjusted models 
that included calendar time as a covariate the association was attenuated in all three years. 
Similarly, in year one the unadjusted hazard ratio for a previous ARI within 28 days was 
significantly higher than those without, but after adjustment the association was attenuated and 
was no longer significant. In year four the point estimates of the hazard ratio for all measures of 
prior ARI were less than one, suggesting a decreased risk of influenza, but were not statistically 
significant. 
In models examining the effect of cumulative number of previous ARI we also found no 
evidence of an association with influenza. In year three unadjusted models produced a 
statistically significantly higher hazard of influenza for those with one previous ARI, but after 
adjustment this association was attenuated and no longer statistically significant.  
Multi-state models 
We examined the unconditional probability of transitioning directly between state one 
(healthy) and state three (influenza infection) and compared it to transitioning from state two 
(previous ARI) to state three using multi-state models. Examining plots of the transition 
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probabilities revealed a slightly higher likelihood of being infected with influenza for those who 
had a previous ARI than for those who did not in all four years.  The differences are particularly 
evident in years one and three, and are consistent with the results of other models. The 
confidence intervals for these estimates, however, were wide and included the transition 
probabilities from a healthy state to influenza (i.e. no previous ARI). Further, the hazard for the 
transition between the previous ARI and influenza states was not statistically different from the 
hazard for the transition between healthy and influenza infection states. 
Vaccination and detection of non-influenza respiratory viruses 
We found no evidence of an association between receipt of the influenza vaccine and 
detection of a non-influenza respiratory virus during any of the four years of study. Point 
estimates are all near one and confidence intervals include the null hypothesis (Figure 4-4). 
Discussion 
We chose to focus this analysis on the risk of influenza after a previous ARI primarily 
due to the fact that most of the non-influenza respiratory virus infections that occur locally 
happen prior to the peak period of influenza transmission. We did not detect an association 
between previous ARI and the risk of influenza over four years of surveillance data collected 
from the HIVE study. The unadjusted effect estimates suggested an increased risk of influenza 
after any previous ARI, particularly for those illnesses that occurred more than 8 weeks after the 
previous illness, but were not statistically significant. This observation could be attributed to 
many factors, one example being an underlying susceptibly to respiratory infections that is not 
completely captured by high-risk health conditions. In addition, in models adjusting for potential 
confounders we observed effect estimates that varied substantially by study year and inclusion of 
calendar time in these models substantially altered the effect estimates. There are a number of 
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potential explanations for these findings including annual variations in timing and type/subtype 
of the influenza and other virus epidemics, intensity of circulation of influenza and other viruses, 
and the duration of surveillance.  These results suggest that calendar time is an important 
confounder when examining the effects of respiratory pathogen interaction on virus specific 
outcomes and future studies should take this into account in models that attempt to estimate 
specific virus-virus interactions. This work examined a different aspect of the potential viral 
interference that was proposed by Cowling et al. However, in addition to the primary analyses 
described above we evaluated the effect of influenza vaccine on the risk of ever having an ARI 
with a non-influenza respiratory virus detected and found no association. 
We used a variety of techniques to estimate the effect of previous ARI on risk of 
influenza, including several definitions for the exposure of interest and multiple modeling 
techniques. While the lack of a significant finding could point to sample size issues (the 
confidence intervals were particularly broad in years two and four) the consistent finding of no 
effect with each of the various methods points to a real lack of association. For the multi-state 
model approach we assumed a Markovian process in which the transition intensity does not 
depend on factors other than the previously occupied state, including duration of time spent in 
that previous state. While this assumption may be violated, assuming a constant Markov process 
allows us to estimate the transition probabilities and standard errors using a likelihood approach. 
The models used here all rely on standard statistical methods that assume independence of the 
outcome and, therefore, may be misspecified and biased in ways we are unable to predict. 
Clearer inferences may, therefore, be draw from studies that use dynamic systems approaches to 
model virus-virus interaction. 
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There are several important implications of the data available from the HIVE study in 
terms of our ability to examine viral interactions. First, in this analysis, we use previous ARI as a 
proxy for previous virus infection because we wanted to limit the possibility of underestimating 
the exposure. Approximately two-thirds of all illnesses reported to the HIVE study during the 
four surveillance periods were associated with identification of a respiratory virus. While the 
panel detects several viruses that are commonly associated with respiratory illness there are 
additional viruses that were not examined. In addition specimens may have been collected up to 
seven days after the onset of illness, meaning that viral etiologies may not have been identified if 
the virus was no longer shedding; this may be particularly important among adults [112]. Despite 
the advantages of using previous ARI as opposed to previous virus infection; it likely 
overestimates the prevalence of exposure. On the other hand, RT-PCR is sensitive for the 
detection of influenza and there is, therefore, unlikely to be information bias in the outcome [95]. 
In addition, we are unable to evaluate the specific hypothesis that innate immunity is protective 
over a short duration (e.g two weeks) because the case definition specifically limited a new 
illness within two weeks of the previous onset date to those that included a new instance of 
subjective fever. Finally, our choice for modeling calendar time assumed that the change in risk 
of influenza over time was linear. More flexible strategies for modeling the change in risk over 
time (e.g. dichotomous variables for two-week blocks) may more satisfactorily represent the true 
change in risk of influenza, but were not feasible given our sample size.  
Despite these issues the prospective cohort study is likely an effective design to evaluate 
these types of interactions. While some recent studies have hypothesized viral interaction via the 
innate immune response, our findings are in agreement with others that did not detect any 
association that could indicate such an interaction. To answer this question more thoroughly 
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though it will be important to focus on virus specific interactions. Particularly of interest are 
those respiratory viruses that activate similar innate immune responses or circulate around the 
same time of year. In addition, longitudinal specimens collected during the same illness or during 
acute and convalescent periods may help to better characterize the duration of shedding and 
allow for estimates of time at risk for viral interactions. Alternative modeling approaches will be 
essential to make sense of complex longitudinal data sets.  
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Figure 4-1. Multi-state model describing the transitions between the initial state (health) and absorbing state (influenza infection), and 
both directly and via a separate pathway with an intermediate state (previous ARI) 
  State%1%Healthy%
State%3%In.luenza%Infection%State%2%Non7in.luenza%ARI%
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Table 4-1. Characteristics of individuals with 1 compared to those with 2 or more ARI over four years of HIVE Study Surveillance 
 
 
 
 
 
 
 
 
 
 
1 Percent of individuals reporting any illness during the given surveillance period (i.e. row percent) 
 2 Percent of individuals for each category of number of ARI within the given surveillance period (i.e. column percent) 
  
  2010-2011 (N=1441) 2011-2012 (N=943) 
 0 ARI 1 ARI 2+ ARI 0 ARI 1 ARI 2+ ARI 
  n % n % n %   n % n % 
Total1 838 58.2 365 25.3 238 16.5 668 70.8 191 20.2 84 8.9 
Female2 415 49.5 183 50.1 130 54.6 325 48.6 95 49.7 43 51.2 
             Influenza Vaccine2 495 59.1 225 61.6 146 61.3 379 56.7 119 62.3 56 66.7 
             High Risk Condition2 86 10.2 45 12.4 28 11.8 74 11.1 32 16.8 3 3.6 
Age Category 
< 5 97 11.6 72 19.7 64 26.9 67 10.0 23 12.0 22 26.2 
5 to 11 225 26.8 97 26.6 70 29.4 204 30.5 62 32.4 23 27.4 
12 to 17 138 16.5 47 12.9 29 12.2 116 17.4 29 15.2 4 4.8 
18 to 49 336 40.1 137 37.5 71 29.8 249 37.2 69 36.1 34 40.5 
50 + 42 5.0 12 3.3 4 1.7 32 4.8 8 1.2 1 1.2 
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Table 4-1 Continued 
 
   2012-2013 (N=1426) 2013-2014 (N=404)   0 ARI 1 ARI 2+ ARI 0 ARI 1 ARI 2+ ARI 
 n % n % n %   n % n % 
Total1 767 53.8 397 60.0 262 40.0 646 61.5 255 24.3 149 14.2 
Female2 348 45.4 214 53.9 150 57.2 321 49.7 122 47.8 89 59.7 
             Influenza Vaccine2 431 56.2 236 59.5 183 70.0 416 68.1 162 65.3 99 66.9 
             High Risk Condition2 80 10.6 28 7.1 26 10.0 121 18.7 47 18.4 26 17.5 
             Age Category2 
< 5 87 11.3 55 13.9 75 28.6 51 7.9 36 14.1 37 24.8 
5 to 11 222 28.9 111 27.9 71 27.1 195 30.2 78 30.6 42 28.2 
12 to 17 133 17.3 58 14.6 21 8.0 139 21.6 32 12.5 8 5.4 
18 to 49 288 37.6 157 39.6 91 34.7 220 34.1 101 39.6 59 39.6 
50 + 37 4.8 16 4.0 4 1.5 40 6.2 8 3.1 3 2.0 
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Figure 4-2. Proportion of illnesses that are influenza positive among illnesses with no previous ARI and among those with a previous ARI by 
two-week intervals of the difference between the onsets of illness. 
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Table 4-2. Unadjusted relative risk (RR) of Influenza for illnesses with a previous ARI (using various methods to define previous ARI) 
compared to those without a previous ARI 
  2010-2011 2011-2012 2012-2013 2013-2014 
Predictor  RR 95% CI RR 95% CI RR 95% CI RR 95% CI 
Previous ARI 1.32 0.94-1.86 1.18 0.24-5.79 1.21 0.82-1.78 0.55 0.82-1.78 
 
        
Previous ARI within 28 
days 1.44 0.80-2.59 0.47 0.01-19.45 0.81 0.39-1.70 1.06 0.39-1.70 
 
        
Cumulative previous 
ARI         
1 1.28 0.85-1.93 0.82 0.08-8.11 1.37 0.9-2.10 0.71 0.32-1.59 
2+ 1.38 0.85-2.24 0.35 0.02-5.20 1.001 0.62-1.60 0.35 0.12-0.97 
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Table 4-3. Cox-proportional hazard models describing the hazard ratio HR for subjects with a previous ARI (using various methods to define 
previous ARI) compared to those without a previous ARI 
  2010-2011 2011-2012 2012-2013 2013-2014 
Model HR 95% CI HR 95% CI HR 95% CI HR 95% CI 
Any Previous ARI         
Unadjusted 1.33 0.94-1.86 1.20 0.54-2.66 1.46 1.01-2.11 0.65 0.35-1.17 
Adjusted1 0.76 0.53-1.09 0.98 0.37-2.58 1.38 0.96-1.99 0.89 0.51-1.56 
Previous ARI within 28 
days         
Unadjusted 2.08 1.20-3.60 0.53 0.07-3.87 1.00 0.51-1.94 0.42 0.10-1.73 
Adjusted1 1.43 0.83-2.44 0.47 0.06-3.81 1.16 0.61-2.20 0.52 0.11-2.41 
Cumulative previous 
ARI         
Unadjusted         
1 1.32 0.89-4.97 1.32 0.49-3.56 1.64 1.08-2.50 0.85 0.43-1.69 
2+ 1.35 0.83-2.21 1.08 0.17-8.55 1.23 0.72-2.10 0.40 0.14-1.12 
Adjusted1         
1 0.77 0.51-1.18 1.22 0.41-3.66 1.37 0.89-2.09 0.95 0.47-1.94 
2+ 0.74 0.46-1.19 2.84 0.5-23.06 1.40 0.81-2.42 0.74 0.26-2.12 
 
 
1 Adjusted models include variables for age category, influenza vaccination, high risk health conditions, and time difference between onset and 
peak influenza transmission 
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Figure 4-3. Transition probabilities from multi-state models 
 
1 Transition from 1 to 3 is the probability of moving from healthy state (i.e. no previous ARI) to influenza 
infection state 
2 Transition from 2 to 3 is the probability of moving from non-influenza ARI (i.e. any previous ARI) and 
influenza infection state 
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Figure 4-4. Odds Ratio of any non-influenza respiratory virus detection for vaccinated vs. 
unvaccinated in the HIVE Study over four years 
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Chapter 5. Conclusions 
 
In this dissertation we make use of data collected during the first four years of the 
Household Influenza Vaccine Effectiveness (HIVE) Study. The primary objectives of these 
analyses are to describe the factors associated with influenza vaccine uptake and to examine viral 
interference as a potential phenomenon. In the four years since the HIVE Study began the scope 
of the study has broadened substantially to include laboratory testing for non-influenza 
respiratory viruses, collection of serum specimens for the detection of anti-influenza antibodies, 
surveys to assess parameters that may be useful in transmission models (e.g. primary caregiver 
during ARI), and studies of bacterial carriage in the oropharynx during ARI. The various topics 
addressed here are additional examples of the versatility of a prospective cohort study. Given this 
flexibility, prospective cohort studies of acute respiratory illness in households should continue 
to play an important role in the descriptive epidemiology of respiratory virus infections, 
influenza vaccine effectiveness, and studies of respiratory virus transmission.  
In the final chapter of this dissertation we will review the main findings of each analysis, 
describe the advantages and disadvantages of the selected approach, briefly place those findings 
in context of the larger body of scientific literature, and discuss the public health implications of 
this work. Finally, we will address overall strengths and limitations of this dissertation and 
highlight opportunities for future work in these fields of study. 
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Vaccine uptake 
The first analysis of this dissertation uses a Health Belief Model framework to examine 
factors that are associated with receipt of seasonal influenza vaccine in households with children 
[113]. Consistent with our hypothesis, perceived barriers and perceived benefits were both 
associated with receipt of seasonal influenza vaccine in both adults and children. In addition, we 
found that cues to action such as doctor recommendation, and perceived susceptibility were 
significantly associated with increased likelihood of vaccine receipt among adults. Similarly, 
parents reporting higher perceived severity were more likely to vaccinate their children. The 
observed effects of perceptions of susceptibility, severity, and benefits were more pronounced at 
low cues to action for children, as were the effects of perceptions of barriers and severity among 
adults.  
There are two major ways that this analysis advances the previous studies of influenza 
vaccine uptake. The first is that we include adults and children in the same household. Many 
studies have examined determinants of vaccination in special populations but very few studies 
have queried community dwelling adults and children along these same lines, and no previous 
studies have been conducted among entire households [3, 5-8, 10, 47, 51, 53]. The second is 
consistent use of a theoretical framework based on the Health Belief Model, which represents a 
major strength in both the design of the survey and the analysis of the data [71]. Despite these 
advantages the HIVE Study population is unique and generalizability to external populations 
may be limited.  
Additionally, we used documented influenza vaccination status rather than relying solely 
on self-report or behavioral intention, outcomes that are susceptible to misclassification. 
Consistent with findings based on self-reported vaccination or intention, we found that 
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perception of benefits, barriers, and cues to action were associated with documented receipt of 
influenza vaccine during the 2010-2011 season [3, 4, 9, 49]. Doctor and family recommendation 
have been previously shown to influence vaccine uptake [4, 9, 49]. We demonstrated not only 
that these factors were associated with vaccination in adults and their children, but also that the 
effect of other health belief model constructs were modified by these cues to action. 
Public Health Implications 
These findings could be informative in terms of developing targeted vaccine campaigns. 
Perceived benefits and barriers are most strongly associated with vaccine receipt. Therefore, 
public health messages aimed at increasing parental perception of benefits and reducing the 
perceived barriers associated with influenza vaccine may, be particularly effective strategies to 
increase vaccine uptake. It is also important to note that external motivators, such as doctor 
recommendation, have the potential to modify the effect of various factors that influence the 
vaccination decision. Educational materials created for health care providers, particularly 
pediatricians, that emphasize the role they can play in this important preventive health decision 
could be another avenue to increase vaccine uptake.  
Viral interference 
 The second and third analyses of this dissertation aim to use different methods to 
examine the phenomenon of viral interference that has been hypothesized in ecologic studies [2, 
11, 83, 84, 98] and, more recently, in individual based studies [12, 108].  
Aim Two 
The second analysis uses a time-series approach to examine cross-correlations between 
viral incidences. We further evaluated the predictive ability of one time-series on the others by 
conducting Granger causality tests. We found evidence that the incidences of common 
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respiratory viruses detected in association with a symptomatic illness were correlated at the 
ecologic level, but that these correlations varied with respect to the timing of the individual 
outbreaks and across study years. Additionally, we sought to quantify virus specific data in terms 
of co-detections and prior detections. We observed similar proportions of co-detection among the 
four most frequently detected viruses in year one and slightly larger proportion of co-detections 
in year three for RSV. In terms of prior virus detection we found that rhinovirus was much more 
likely than the others to be detected during a preceding illness. 
Strengths and Limitations 
We used an innovative approach, taking statistical methods that are generally applied to 
the analysis of economic data to investigate correlations among trends in viral incidence. We 
used data from two years of the HIVE Study, which proved to be essential since the results 
differed by year. However, these two years were analyzed separately and compared. It is, of 
course, possible that past seasons may predict future seasons within the same virus. Longer time 
series, potentially on the order of five years (or more) of consecutive data, are likely necessary to 
fully understand this issue. Additionally, the methods we used for determining weekly viral 
incidence may lead to inaccurate estimates of the actual weekly incidence. We did not collect 
specimens from asymptomatic individuals and we relied on self-report of symptomatic illness 
both of which could lead to an underestimate of viral incidence. However we also assume 
complete immunity after the first infection, and therefore removed all detected cases from the at 
risk population for the subsequent weeks of surveillance. This assumption is very likely violated 
and, particularly with respect to rhinovirus, may lead to over estimates of weekly incidence. 
Importantly, this analysis describes Granger, or ecologic, causality which does not satisfy the 
causal criteria as we think of it in the epidemiologic sense. These methods are useful for 
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examining if one time series can predict another, but they do not suggest that an increase (or 
decrease) in incidence of one virus causes an increase (or decrease) in another. Along the same 
lines, due to the ecologic nature of this analysis we are unable to account for potential 
confounders, such as influenza vaccination, that may influence risks of infection at the individual 
level. Finally, there are additional data that could be taken into account in order to fully evaluate 
this phenomenon; relative humidity, and ambient air temperature are prime examples. 
Previous studies 
This ecologic analysis expands upon previous work by statistically evaluating the visual 
trends that have been reported and used as a basis for hypothesizing viral interference [2, 11, 58, 
60, 84]. While we find that the incidences of virus detection are indeed correlated it remains 
unclear whether that correlation is indicative of antagonism or synergism.   
Aim Three 
Finally, the third analysis takes an individual based approach to examine the risk of 
influenza after a previous ARI. We used a variety of methods to estimate the effect of previous 
ARI on risk of influenza, including multiple statistical models and several definitions for the 
exposure of interest. Overall, we did not detect an association between previous ARI and the risk 
of influenza over four years of surveillance data collected from the HIVE study. While the lack 
of a significant finding could be due to relatively small sample sizes, the consistent finding of no 
effect with each of the various methods points to a real lack of association.  
Strengths and limitations 
There are several important implications of the data available from the HIVE study in 
terms of our ability to examine virus-virus interactions. First, in this analysis, we use previous 
ARI as a proxy for previous virus infection because we wanted to limit the possibility of 
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underestimating the exposure. Approximately two-thirds of all illnesses reported to the HIVE 
study during the four surveillance periods were associated with identification of a respiratory 
virus [39]. However, increasing time from onset, age and other factors may decrease the 
likelihood of virus detection. In addition, the case definition for an acute respiratory illness in the 
HIVE study limits our ability to evaluate the specific hypothesis that innate immunity is 
protective over a short duration (e.g two weeks). Finally, our choice for modeling calendar time 
assumed that the change in risk of influenza over time was linear around the peak of the 
influenza season. More flexible strategies for modeling the change in risk over time (e.g. 
dichotomous variables for two-week blocks) may more satisfactorily represent the true change in 
risk of influenza, but were not feasible given our sample size. The relationships here are very 
likely quite complex, therefore clearer inferences may be drawn from studies that use dynamic 
systems approaches to model virus specific interaction. 
Previous Studies 
The primary objective of this analysis differs from the few previously conducted 
individual studies of viral interference. Specifically, we focused on the risk of influenza after a 
previous ARI for two reasons: 1) the period of influenza circulation was covered by all four 
study years allowing us to make maximum use of the collected data and 2) the majority of non-
influenza respiratory virus infections that occur locally happen prior to the peak period of 
influenza transmission. In the first of the previous studies Cowling et al (2012) suggested that 
those who are vaccinated were not infected with influenza, therefore there was a lack of innate 
immune response that made them more susceptible to non-influenza respiratory virus infection 
[12]. Sundaram et al (2013) refuted these findings using patients recruited for a test-negative 
study of influenza vaccine effectiveness in ambulatory care settings [13]. As a secondary aim of 
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this analysis project we also estimated the association between influenza vaccine and detection 
of a non-influenza respiratory virus and find no effect in any of the four years. This 
supplementary analysis confirms the findings of the primary analysis in that there is no evidence 
of viral interference.   
Implications of viral interference findings  
Viral interference, if a real phenomenon, could have several implications for public 
health. There is an oft-repeated sentiment that the only thing predictable about influenza in 
particular is its unpredictability. We observe significant correlations between coronavirus, 
influenza, and RSV across both years, albeit at different lag times. Additional data or different 
modeling techniques may be helpful in obtaining a clearer picture of these complex associations. 
If a consistent relationship can be teased out of ecologic trends it could be helpful to forecast not 
only the timing, but also the intensity, of future outbreaks [114]. This possibility is exciting to 
many in the influenza world as it could lead to better prevention strategies [115]. 
Further implications of viral interference could be important to influenza vaccination in 
particular. The live-attenuated influenza vaccine (LAIV) is now a quadrivalent formulation that 
carries a preferential recommendation for children two to eight years old [116]. Adding 
additional strains of the virus to the live vaccines, for example, may be counterproductive if 
those viruses interact in an antagonistic fashion. LAIV confers protection by infecting the 
recipient with a weakened version of the virus, if some strains are not infecting due to viral 
interference they could, conceivably, not provide the same level of protection. In addition, there 
has been a well-documented surge in anti-vaccination sentiment [117-119]. Recently an editorial 
in the British Medical Journal decried the value of the influenza vaccine, and claimed that ‘the 
threat of influenza appears overstated’ [120]. Given the current skepticism surrounding vaccines 
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an increased risk of other respiratory infections could be used to call into question the safety, 
which could lead to a reduction in vaccine uptake. A better understanding of the pathogenesis of 
ARI associated with viral infections such as influenza, including the risk of re-infection and 
infection after a previous ARI, could be useful in risk communication.  
 Finally, there are implications for influenza vaccine effectiveness studies that use test-
negative designs. If vaccinated individuals were indeed at a higher risk of non-influenza 
respiratory infections effectiveness could be overestimated [108, 121]. The extent of this 
potential bias depends on both the risk of influenza and the duration of immunity, therefore, 
further studies clarifying viral interference are critical. 
Overall strengths and limitations 
This dissertation makes use of an ongoing prospective cohort study to address questions 
of relevance to the scientific literature regarding influenza vaccination and viral interference. 
Prospective cohort studies are less likely to introduce selection bias than other observational 
designs [122]. Nevertheless, selection bias is of particular concern in the case of the first 
analysis, in which we see substantially higher proportion of vaccinated individuals than the 
general population [70]. The majority of HIVE participants are enrolled before vaccine becomes 
available locally and/or before they make the decision to be vaccinated. Further, children tend to 
be vaccinated at higher rates than the rest of the population and approximately 60% of our study 
population are children [70]. The HIVE Study population is, in fact, unique in a number of other 
ways that may limit our ability to generalize these findings to outside populations. The study 
population is predominately white, and self-reported subjective social position (SSP) is rather 
high. Further, educational attainment and rates of insurance coverage are both remarkably high. 
Many of these factors have been linked to vaccination in previous studies [80]. Therefore, the 
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high rates of vaccination in our study population likely point to limited generalizability, 
particularly with respect to the first analysis, as opposed to selection bias. Importantly, the study 
population is representative of the source population from which they were drawn in terms of 
these characteristics. 
It is further worth mentioning that these data were not collected specifically for the 
purpose of identifying viral interference. As a result, we are missing some potentially valuable 
information that could help paint a clearer picture of this complicated relationship. As a specific 
example, we are limited in our ability to detect short term associations between respiratory 
viruses based on our case definition. Furthermore, the correlated trends we observe could be due 
to factors that are unrelated to viral interactions such as relative humidity and ambient air 
temperature. Again, the flexibility of the prospective cohort design allows us to collect additional 
information or modify case definition as we see fit for future studies. 
Finally, it is important to note that our methods of laboratory confirmation of respiratory 
virus infection, while highly sensitive and specific, are neither perfectly sensitive nor perfectly 
specific [94, 95]. Though HIVE study staff are carefully trained there are many opportunities 
from specimen collection to laboratory processing for these specimens to be compromised. There 
is a chance, therefore, that we may be misclassifying virus specific data. Further, while the RT-
PCR assay we use detects several viruses that are commonly associated with respiratory illness 
there are additional viruses that were not examined. Moreover, all respiratory specimens may 
have been collected up to seven days after the onset of illness, meaning that viral etiologies may 
not have been identified if the virus was no longer shedding; this may be particularly important 
among adults [112]. In short, detection of a virus from respiratory specimens is a very delicate 
process; while we are confident in our methodology and training, the numbers we are dealing 
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with on an annual basis are relatively small, and even a minor amount of misclassification could 
be relevant. 
Future work 
 We will continue to collect and analyze data related to both of the topics addressed in this 
dissertation in future years of the HIVE Study. In addition, existing household cohorts in other 
settings are well positioned to collect these data in their own unique populations in order to 
provide better context and understanding to our observations [90, 123].   
In terms of the HIVE study, we plan to continue to examine factors associated with 
influenza vaccine receipt. Survey data is collected from adult participants in the HIVE study 
each year regarding emotional benefits of influenza vaccination based on previous work in health 
care providers [10]. Specific questions that can be addressed include: 1) longitudinal changes in 
attitudes and for those individuals that participated in multiple years of the study and 2) whether 
attitudes, or changes in attitudes, are associated with prior vaccine receipt, prior influenza 
infection, and actual or perceived influenza vaccine effectiveness.  
We further plan to use incidence data from four consecutive study years with comparable 
duration of surveillance, beginning with the 2012-2013 season, to investigate some of the 
questions that remain unanswered in terms of longer time series and the predictive ability within 
viruses. In addition we will to create stochastic compartmental models to address the issues of 
depletion of susceptible individuals that allow for enough variation in weekly incidence to make 
use of the time-series approach. Finally, we plan to create additional compartmental models like 
those recently used to examine the interaction between Streptococcus Pneumoniae and influenza 
to examine viral interference at the individual level [106, 107]. Prospective cohort studies of 
acute respiratory illness in the household setting have provided and continue to provide relevant 
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information on an immensely important issue regarding human health.  Collectively, this 
dissertation highlights the ongoing value these studies by illustrating the breadth of topics that 
can be investigated. 
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